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CHAPTER I 
 
INTRODUCTION 
 
Inflammation and Disease 
Inflammation and Oxidative Stress 
The hallmarks of inflammation have been recognized for millennia, as documented by 
writings from the ancient civilizations of Mesopotamia, Egypt, and Greece.7 The Greek physician, 
Celsus, defined the clinical manifestations associated with inflammation: rubor (redness), tumor 
(swelling), calor (heat), dolor (pain),8 with a fifth sign, functio laesa (loss of function), added in 
the 19th century by Rudolf Virchow.9 Our understanding of inflammation has changed drastically 
over the years. Acute inflammation was predominantly regarded as a disease prior to the late 18th 
century when surgeon and anatomist John Hunter proposed a beneficial role.9 Today, acute 
inflammation is known to be a beneficial process that wards off infection and leads to the repair 
of damaged tissues.  
The inflammatory response is initiated in response to stimuli emanating from sites of tissue 
injury that may be caused by pathogens, environmental toxins, trauma, etc. A cascade of events 
contributes to the inflammatory response as a whole, but one important component is production 
of reactive oxygen (ROS) and nitrogen species (RNS) by various immune cells at the primary site 
of inflammation (Figure 1).10,11 The persistence of a bodily injury or the lack of resolution of the 
inflammatory response result in the development of chronic inflammation. Under these conditions, 
nearby host cells are continuously exposed to ROS and RNS, and the imbalance of oxidant 
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production relative to antioxidant defense systems in the cell contributes to oxidative stress and 
disease generation.  
  
 
Inflammation and Diseases 
The link between inflammation and disease has long been hypothesized. In 1863, Rudolf 
Virchow noted the presence of leukocytes in neoplastic tissue and proposed that the 
“lymophoreticular infiltrate” suggested the origin of cancer at sites of chronic inflammation.12 
Much more is now known about Virchow’s initial observations. There is a growing body of 
Figure 1. Generation of reactive species in the immune response. During an inflammatory response, macrophages and 
neutrophils are recruited to the site of infection or injury and generate a multitude of reactive species to combat the 
pathogen. These reactive metabolites can damage pathogen and host cellular molecules, including proteins, nucleic 
acids, carbohydrates, and lipids. Reprinted by permission from Macmillan Publishers Ltd: Nature Protocols 
Taghizadeh et al. (2008) Nat. Protoc. 3(8):1287-98. Copyright 2008.3 
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evidence suggesting that many malignancies are the result of or exacerbated by chronic 
inflammation and oxidative stress. ROS and RNS can damage lipids, proteins, and DNA in 
proliferating host cells, and persistent DNA damage can result in mutations, deletions, and 
rearrangements.13 Loss-of-function mutations in tumor suppressor proteins, such as p5314 and 
PTEN,15  or dysregulation of oncogenes, such as Ras16 and Myc17, can contribute to aberrant cell 
growth, thereby promoting tumorigenesis. 
Virchow’s initial hypothesis has been supported by a multitude of studies over the past 150 
years and has expanded to include diseases other than cancer. A large body of work has supported 
the role of inflammation and oxidative stress in the pathogenesis of neurodegenerative disease. 
From an epidemiological perspective, long-term use of nonsteroidal anti-inflammatory drugs has 
a beneficial effect on Alzheimer’s disease (AD) and Parkinson’s disease (PD), suggesting that a 
suppression of inflammation inhibits disease progression.18-20 Genetic polymorphisms in 
inflammatory cytokines, most notably interleukin-1, increase the risk of developing AD and 
PD.21,22 Additionally, a number of in vitro and in vivo models have shown that reduction in 
inflammatory processes alleviates neurologic symptoms.23-26 Thus, neurodegenerative disease 
initiation and progression appear to be strongly correlated with inflammation. 
Inflammation also plays a large role in the development of atherosclerosis. Atherosclerotic 
plaques are composed of a large number of immune cells, particularly macrophages and T-cells.27 
In fact, the majority of the cells present during plaque formation are lipid-laden macrophages 
known as foam cells. Activation of these immune cells results in the production of pro-
inflammatory cytokines, such as tumor necrosis factor (TNF) and interferon-g (INFg).28 Studies 
have shown beneficial outcomes with the use of peroxisome-proliferator-activated receptor 
(PPAR) activators that decrease TNF and INFg secretion by inhibiting T-cell activation. Inhibition 
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of immune cell activation and reduction in pro-inflammatory mediators is a promising therapeutic 
approach to reducing the progression of atherosclerosis.29  
  
Lipid Peroxidation 
Chemistry of Oxidant Formation During Inflammation 
While Celsus was able to describe the physical manifestations of inflammation two 
millennia ago, the cellular damage that occurs during chronic inflammation has only been 
appreciated for the past half-century. In response to an inflammatory stimulus, such as recognition 
of a pathogen by cell surface receptors, the cells produce a multitude of bioactive peptides, 
cytokines, and chemokines, to initiate the inflammatory response. Synthesis of these molecules 
helps to recruit leukocytes, most notably neutrophils and macrophages, to the site of the stimulus. 
These cells will then contribute to a respiratory burst, consisting of a rapid release of ROS and 
RNS. 
Under normal cellular conditions, the balance between pro-oxidant generation and anti-
oxidant defenses is well maintained. The respiratory burst generates large amounts of oxidants in 
an attempt to combat the inflammatory stimulus. NADPH oxidases catalyze the reaction that 
produces superoxide (O2·–), the one election reduction of molecular oxygen. In leukocytes, 
NADPH oxidase 2 (NOX2) is the main enzyme responsible for this reaction (Figure 2). Upon 
leukocyte activation, NOX2 and the constitutively associated p22phox are translocated to the plasma 
membrane from intracellular vesicles.30,31 Exchange of GDP for GTP contributes to activation of 
Rac kinase, which phosphorylates p47phox, causing a large conformational change allowing for its 
direct association with p22phox.32,33 The conformational change in p47phox also enables the 
recruitment of p67phox and p40phox to produce the fully active NOX2 complex.34,35  
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The NOX2 complex comprises a transmembrane redox chain, with an electron donor 
(NADPH) on the cytosolic side and bound oxygen on the luminal side of the plasma membrane. 
Electrons are transferred from NADPH to FAD by p67phox. A single electron is then transferred 
from fully reduced FADH2 to the inner heme within NOX2. The inner heme then donates the 
electron to the outer heme prior to accepting the second electron from partially reduced FADH. 
Oxygen that is bound to the outer heme accepts the electron bound to the outer heme, resulting in 
the generation of O2·– on the luminal side.36 
A
B
NOX2
p22phox
RacGDP
RhoGDI
p67phox p47phox
p40phox
p67phox p47phox
p40phox
NOX2
p22phox
RacGTP
NADPH NADP+ +H+
2O2 2O2·-
2e-
Figure 2. NADPH oxidase activation. A) Inactive NADPH oxidase (NOX2) is in the membrane associated with 
p22phox. Proteins required for activation remain in the cytosol, and GDP is bound to Rac. B) Upon inflammatory 
stimulation, GTP binds to Rac, and NOX2 binding partners translocate to NOX2. NADPH is hydrolyzed to NADP+ 
and H+ with a 2e- transfer. Molecular oxygen is reduced by NOX2 to O2·-. Figure adapted with permission from 
McCann and Roulston Brain Sci. (2013) 3(2):561-598. Copyright 2013.4 
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While its production contributes to the respiratory burst, O2·– is not a strong oxidant and 
has a short half-life in aqueous solution. Dismutation of O2·– occurs non-enzymatically and 
enzymatically, by the activity of superoxide dismutase (SOD), to form hydrogen peroxide (H2O2) 
and O2.37 H2O2 can undergo the Fenton reaction to form hydroxyl radical (OH·).38,39 Nitric oxide 
(NO·), which is produced as a signaling molecule in high quantities during the respiratory burst 
by inducible nitric oxide synthase (iNOS)40 can react with O2·– at near-diffusion-controlled limits 
to produce the strong oxidant peroxynitrite (ONOO–).41 
ROS can also be generated as a result of normal physiological processes. Aerobic tissues 
require oxidative respiration to synthesize ATP. The electron transport chain within mitochondria 
is a carefully controlled system that couples the movement of electrons to the creation of a proton 
gradient necessary to produce ATP. Leakage of electrons from the electron transport chain results 
in the formation of O2·– in the intermembrane space and the mitochondrial matrix.42 Concentrations 
of O2·– within the matrix are estimated to range from 10-200 pM.43,44 SODs act in both the 
mitochondria and the cytosol to remove the endogenously generated O2·– to limit its negative 
effects.45  
The collection of radical and non-radical reactive species is generated during inflammation 
to combat the sources of the inflammatory stimuli, but host cells can also be caught in the cross-
fire. ROS and RNS can react with DNA to form DNA adducts or produce strand breaks, both of 
which can contribute to mutations. Oxidants can also directly react with the side chains of amino 
acids on proteins. An example is the reaction of peroxynitrite with tyrosine to form nitrotyrosine, 
a modification that can disrupt protein function.46 Of particular interest is the reaction of strong 
oxidants, OH· and ONOO–, with polyunsaturated fatty acids (PUFAs) in cell membranes, 
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contributing to lipid peroxidation and the production of electrophiles. These electrophiles can react 
with proteins to form adducts that contribute to dysregulation of protein function.  
 
Formation of Lipid Electrophiles 
As noted above, ROS can react directly with DNA and proteins to form site-specific 
oxidative modifications. In addition, ROS can abstract hydrogen atoms from the bis-allylic 
position of PUFAs within cell membranes. Oxidation of PUFAs occurs via the common free 
radical initiation, propagation, and termination mechanism (Figure 3).47 First, a radical initiator 
abstracts a hydrogen atom from a methylene group located between two double bonds of the PUFA 
(Figure 4). The carbon-to-hydrogen bonds at this position are relatively weak, allowing them to be 
readily broken.47,48 The product is a delocalized radical across the carbon centers that make up the 
adjacent cis double bonds. This resonance-stabilized pentadienyl radical intermediate can proceed 
to the propagation steps of the radical mechanism, which includes oxygen addition, and hydrogen 
atom transfer. The addition of molecular oxygen to the carbon-centered radical leads to the 
formation of the lipid peroxyl radical. Transfer of a hydrogen atom from a nearby PUFA to the 
peroxyl radical results in formation of a hydroperoxide (LOOH) with termination of the reaction 
on the original oxidized lipid and propagation of the reaction via the radical formed on the second 
lipid. This step is slow in the overall radical mechanism as evidenced by the low rate constant for 
H-atom transfer,49,50 suggesting that the peroxyl radical is relatively unreactive. Termination of the 
chain involves reduction of the peroxyl radical by a non-PUFA species.  
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An array of LOOH products can be formed as a result of the autoxidation process. In the 
simple example of linoleic acid, an 18 carbon fatty acid containing two cis double bonds, there are 
three possible positional isomeric products. Initial hydrogen abstraction occurs at C-11, resulting 
in a delocalized pentadienyl radical across five carbons. Formation of the peroxyl radical can occur 
Termination LOO•		 +			R•		à nonradicalproducts
Initiation In•			+			LH			à InH +			L•
Propagation
L•			+			O2 à
LOO•			+			LH			à
LOO•
LOOH			+			L•
Figure 3. Radical mechanism of lipid peroxidation. Representative scheme for lipid (LH) peroxidation. An initiator 
radical (In·) abstracts an H-atom from a lipid to form a lipid radical (L·). This can react with molecular oxygen to 
form a lipid peroxyl radical (LOO·). This can act as an initiator to propagate the reaction. In the termination step, the 
lipid peroxyl radical can produce non-radical products. 
RR
RR
O
O
RR
O
OH
RR
HH
Oxidant
RR
+RR
HH
O2
Figure 4. General mechanism of autoxidation of polyunsaturated fatty acids. In the first step, an oxidant abstracts an 
H-atom from the bis-allylic position of a PUFA to form a delocalized radical. This can react with molecular oxygen, 
forming a lipid peroxyl radical that can abstract an H-atom from a nearby PUFA to propagate the reaction while 
terminating itself by the formation of the lipid hydroperoxide. 
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at C-9, -11, or -13, with preference being at C-9 and C-13 in the absence of a good hydrogen 
donor.47,51 Quenching of the peroxyl radical forms 9-, 11-, or 13-hydroperoxy octadecadienoic 
acid (HPODE).52  
 
 
It is the breakdown of the lipid hydroperoxide that mainly contributes to the formation of 
a,b-unsaturated aldehydes.53 4-Hydroxy-2-nonenal (HNE) was originally discovered by Hermann 
Esterbauer as the most cytotoxic product of lipid peroxidation. He identified HNE as a 
R1 R2H H R1 R2 R1 R2O
HO
R1 R2O
O
R1
R2O
O
R1
R2O
OH
R1
R2
R1 R2
O OH
R1 R2
O O
R1 R2
O OH
R1 R2
O O
O2
O2
O2
R1=HOOC(CH2)7
R2=C5H11
R1
R2
O2
R1 R2
OO
R1 R2
OHO
O2
H·
H·
H·
H·
H·
Figure 5. Autoxidation of linoleic acid. Abstraction of an H-atom at the bis-allylic position results in a delocalized 
radical, which can react with molecular oxygen at three different positions to generate peroxyl radicals. These peroxyl 
radicals can be quenched to form the HPODE, or reversed to reform the pentadienyl radical. Reversal results in 
isomerization of the cis double bond and represents a lower energy state. 
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peroxidation product of linoleic acid and arachidonic acid in the presence of ascorbate and FeSO4 
in aqueous solution, as well as from lipid in liver microsomes.54,55 Today, HNE is one of the most 
intensely studied lipid electrophiles, and the mechanism of lipid hydroperoxide fragmentation that 
leads to its formation is widely debated. HNE can be generated from HPODEs or from other 
oxidized w-6 fatty acids by Hock cleavage or b-scission (Figure 6).54,56-60 Both of these 
fragmentation mechanisms can yield additional a,b-unsaturated aldehydes, such as 4-oxo-2-
nonenal (ONE), malondialdehyde, and acrolein.61,62 These electrophilic aldehydes show differing 
levels of reactivity to nucleophilic substrates within DNA and on proteins.  
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R2R1
R1 R2
O
O
R2
R1
O
OH
R1 R2
O
O
R2
R1
O
OH
O
HO
R2
O
O OH
R2R1
R1=C5H11
R2=(CH2)7COOH R2
O
OH
R1 R2
O
O
R1 R2
O
HO
R1
O
OHO
R1
O
OH
R1
O
R1 O
H
Hock cleavage Dimerization
β−scission
Figure 6. Mechanism of formation for HNE from linoleic acid. Two possible routes of HNE formation have been 
proposed from 9-HPODE. Hock cleavage of 9-HPODE followed by an H-atom abstraction produces 4-hydroperoxy-
2-nonenal (HPNE), which is reduced to HNE. In a second possible mechanism, dimerization between 9-HPODE and 
13-HPODE with an additional H-atom abstraction is followed by b-scission of the dimer to produce HPNE then HNE. 
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Mechanisms of Adduction by Reactive Aldehydes 
 HNE and ONE are of particular interest due to the physiologic and pathophysiologic levels 
that have previously been reported. Levels of HNE have been reported to range from 10 µM to as 
high as 5 mM, locally, in response to an oxidative insult.63 The high levels of electrophile can 
contribute to extensive adduction of DNA bases and amino acid side chains. Protein adduction can 
disrupt cell signaling, alter gene expression, inhibit enzymatic activity, and initiate cell death by 
necrosis or apoptosis. 
Since HNE is the most thoroughly studied lipid electrophile, numerous investigations of 
the relative reactivity of HNE with the nucleophilic protein side chains have been reported. 
Michael addition is the most common reaction observed between HNE and the thiol, imidazole, 
and amine of cysteine, histidine, and lysine residues, respectively, and in vitro studies have shown 
that HNE reacts with these residues in the rank order Cys >> His > Lys (Figure 7).64 The hydroxyl 
at C-4 of HNE elicits an electron-withdrawing effect, contributing to increased electrophilicity of 
C-3.63 The Michael adducts are stabilized by the formation of cyclic hemiacetals, and 
modifications on Cys and His are stable while those on the e-amine of Lys are readily 
reversible.64,65 Reduction of the more labile Michael adducts with NaBH4 converts free aldehydes 
and ketones to the corresponding alcohol, making the adduct insensitive to a retro-Michael 
reaction.  
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Schiff base formation can occur by reaction of either HNE or ONE with Lys residues 
(Figure 8A). The products are labile, with adduct reversal occurring upon exposure to weak acid 
or heating;66 however both HNE- and ONE-derived Schiff base adducts have been shown to 
undergo a cyclization to form a stable pyrrole (Figure 8B).67,68 While this reaction occurs at levels 
significantly lower than those of Michael addition, the presence of the pyrrole adducts in diseased 
tissues from patients with Alzheimer’s disease and in plasma of patients with atherosclerosis,69,70 
suggests that they are physiologically relevant and potential biomarkers.  
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Figure 7. HNE Michael adducts. HNE reacts with Cys (top) His (middle) and Lys (bottom) to form the Michael adduct 
(center). These adducts and cyclize to form the hemiacetal (left) or be reduced with NaBH4 to stabilize the adducts 
through reduction of the aldehyde (right). 
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ONE displays unique reactivity toward Lys residues that was unappreciated until recent 
years. There have been numerous studies over past decades that wrongly identified the ONE-Lys 
modification as a Michael adduct due to the corresponding mass shift observed by mass 
spectrometry. In the mid 2000s, work from the Sayre laboratory confirmed that the reaction of 
ONE with Lys resulted in a mass shift of +154 m/z from native Lys, consistent with a Michael 
adduct. However, upon treatment with NaBH4, the +154 m/z peak was replaced with one at +156 
m/z. This mass shift was inconsistent with a reduced Michael adduct, which would result in a +158 
m/z mass shift. The data led to the realization that the 4-ketoamide modification, rather than the 
Michael adduct, was the prevalent ONE adduct on Lys (Figure 8C).71 The group went on to show 
that the 4-ketoamide adduct was chemically stable and long-lived, making it a significant marker 
for protein modifications by ONE.72 
 The ability to form cross-links between two nucleophilic amino acid side chains has 
previously been shown to occur with many a,b-unsaturated aldehydes. In vitro cross-links of HNE 
and ONE have been extensively investigated and characterized.73-77 Consistent with its higher 
reactivity to single modifications,78 ONE also displays a greater ability to form cross-links than 
HNE.73 These cross-links can occur between two Lys residues, a Cys and a Lys residue, or a His 
and a Lys residue.  Oe et al.79 were the first to identify the site-specificity of an ONE cross-link 
O
N
O
O
HNN
A B C
Figure 8. Lysine-specific adducts. A) ONE-derived Schiff base modification on Lys, which can also be formed with 
HNE. B) Cyclic pyrrole adduct derived from ONE or HNE. C) 4-Ketoamide adduct of ONE on Lys. 
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within a protein. Using bovine histone H4, the authors were able to identify an intrapeptide cross-
link between His75 and Lys77 and proposed that an –HAK– motif was necessary for cross-link 
formation. This cyclic modification, containing the imidazole of the His and a Lys-derived pyrrole 
was hypothesized to have biological implications for transcription and gene expression.   
 
Detection of Protein Adducts 
Endogenous and Exogenous Electrophiles 
 There are two main approaches for investigating the effects of lipid electrophiles, each of 
which brings its own advantages and disadvantages. The first explores the generation of 
endogenous electrophiles in intact cells or animals subjected to a stimulus that contributes to an 
acute or chronic inflammatory response. An example is  chronic ethanol consumption, which 
generates a panoply of reactive lipid aldehydes.80 This is clearly the more biologically relevant 
scenario, as electrophiles are generated at physiological/pathophysiological levels at distinct 
locations and can affect relevant cells/tissues. However, the wide diversity of electrophiles that 
may be produced creates a great challenge in the identification of the precise chemical nature of 
the damage. In the absence of exhaustive mass spectrometric methods for the unbiased 
identification of protein adducts, determination of the targets and the adducting species is difficult, 
if not impossible.  
In the exogenous addition approach, the electrophile of interest, such as HNE or ONE, is 
added in a bolus dose to cells or purified proteins. The added HNE can then enter the cells to 
adduct proteins and elicit a cellular response or react directly with the protein in solution. 
Following addition of electrophile to the buffer, lysate, or cell culture medium, samples are 
incubated for a desired amount of time to allow for protein adduction prior to detection, isolation, 
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and/or quantitation. While this approach may not be the most physiologically relevant due to the 
addition of high concentrations of exogenous electrophile, it remains the best approach for 
differentiating the targets of structurally defined electrophiles.  
Regardless of whether endogenous or exogenous electrophile-mediated damage is the 
focus of study, methods are required to capture and identify the targets of that damage. Over the 
years, a variety of techniques have been developed that vary in their specificity and sensitivity. 
The most widely used of these will be discussed below, with a focus on identifying damage caused 
by HNE and/or ONE.  
 
Labeling of Protein Carbonyls 
 HNE and ONE contribute to a constellation of protein modifications, and since their 
original discovery, many methods have been employed to label, detect, isolate, and/or quantitate 
these adducts. While the small difference in structure between the two electrophiles, consisting of 
only two H-atoms, renders ONE much more reactive than HNE, their adducts are nearly 
indistinguishable by many labeling techniques. The majority of labeling methods employs a 
chemical derivatization to tag modified proteins, taking advantage of the free aldehyde that 
remains following Michael addition. These approaches, however, have a number of drawbacks. 
First, they will only detect adducts with a carbonyl, and would therefore not detect Schiff base 
adducts or cross-links. Second, the approach will detect any free aldehyde or ketone, thereby 
lacking the specificity for HNE or ONE adducts. An advantage to some of these approaches is that 
they can be used for labeling endogenously generated protein adducts from structurally similar 
electrophiles, making them ideal for in vivo studies. 
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 Hydrazide chemistry is commonly used for the chemical derivatization of carbonylated 
proteins. Hydrazides react with aldehydes and ketones to form a reducible hydrazone, and a 
number of reagents have been developed to utilize this chemistry (Figure 9). Of particular interest 
is biotin hydrazide, which is used to biotinylate carbonylated proteins, making it amenable to 
avidin detection/capture (Figure 9A). An alternative approach is the use of dinitrophenylhydrazine 
(DNPH) followed by the immunologic detection of carbonylated proteins using antibodies directed 
against DNP (Figure 9B). Although this approach suffers from the lack of specificity noted above, 
an advantage is that it can be used to capture proteins modified by endogenous electrophiles, 
requiring only the presence of a retained carbonyl in the adduct. 
 
  
Click Chemistry of Alkyne-Tagged Electrophiles  
A more recently developed method for protein adduct labeling utilizes click chemistry. 
Originally discovered by Rolf Huisgen in the 1960s,81 click chemistry approaches were refined by 
Barry Sharpless in the early 2000s for application to biological systems.82 The reaction requires an 
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a protein to yield a Schiff base. Reduction of the Schiff base with NaBH4 stabilizes the product. B) DNPH reaction 
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azide and an alkyne, which in the presence of a Cu(I) catalyst, undergo a 1,3-dipolar cycloaddition 
to form a 1,2,3-triazole (Figure 10A). Tris-(benzyltriazolylmethyl)amine (TBTA) can also be 
employed as a triazole ligand to stabilize the Cu(I) during the reaction.83 The application of click 
chemistry to the study of HNE and ONE adducts was pioneered by the Marnett, Porter, and Liebler 
laboratories.5,84,85 Alkyne analogues of HNE (Figure 10B) and ONE (Figure 10C) were 
synthesized to contain a terminal alkyne. These molecules retained the electrophilic reactivity of 
the native analogues, but could be conjugated to azido-biotin compounds to enable isolation and 
detection by avidin affinity methodology (Figure 10D). This approach has provided large 
advantages over the traditional carbonyl detection methods, mainly due to the increased specificity 
and decreased background; however, it is limited to the detection of damage caused by exogenous 
electrophiles. 
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Detection of Chemically Labeled Proteins 
 These various labeling techniques provide different avenues for the detection and isolation 
of adducted protein. Proteome-wide visualization of carbonylated proteins can be achieved by 
western blot. For example, following derivatization with DNPH, carbonylated proteins can be 
detected with anti-DNPH antibodies in what is commonly referred to as an “Oxyblot.” Both biotin 
hydrazide and click chemistry using alkyne analogues allow for detection by western blot using 
streptavidin probes in place of antibodies.  
In proteomic-based approaches, biotin-tagged proteins can be isolated using streptavidin 
beads, washed, and eluted. Proteins are separated by SDS-PAGE and stained with Coomassie blue, 
O
OH O
O
B C
H
N
NHO H
HN
H S
O
O
4
H
N
O
N
2
N N
OHO
Protein
H
N
NHO H
HN
H S
O
O
4
H
N
O
N32
O
OH
Protein
+
CuSO4
TCEP
TBTA
D
A
R1 N N
N R2
N
N
N
R1
R2
+
TBTA
Cu(I)
Figure 10. Click chemistry. A) Representative click chemistry reaction. In the presence of a Cu(I) catalyst and TBTA, 
an alkyne and an azide cyclize to form a 1,2,3-triazole. B) Alkyne analogue of HNE (aHNE). B) Alkyne analogue of 
ONE (aONE). D) Click chemistry scheme developed by Vila et al.5 Adducted proteins are conjugated to an azido-
biotin for selective isolation or detection. 
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allowing for excision of bands for in-gel digestion coupled with LC-MS/MS. Although peptides 
identified by this approach do not contain the adduct, they enable identification of the protein 
targets of adduction. 
 
Whole Proteome Analysis of Adducted Proteins 
 In 2009, Codreanu et al.86 developed the first whole proteome inventory of proteins 
modified by HNE. The authors treated cells exogenously with HNE and used biotin hydrazide to 
biotinylate carbonylated proteins. Following streptavidin capture, isolated proteins were subjected 
to mass spectrometry-based proteomics analysis. This approach identified 1500+ captured 
proteins, but only 417 of these showed a statistically significant increase in adduction with 
increasing HNE. The lack of dose-dependency between adduct amount and HNE concentration 
suggested that a high number of identifications were nonspecific, due either to the reactivity of 
biotin hydrazide with protein carbonyls that did not result from adduction or to non-specific 
binding of proteins to the capture beads. 
 The emergence of the click chemistry approach to study HNE and ONE allowed for more 
in-depth studies into the specific targets of the electrophiles along with a better understanding of 
their differential reactivity. In 2014, Codreanu et al.84 refined their proteomic approach to take 
advantage of the increased specificity of click chemistry. In these studies, cells were treated with 
alkynyl-HNE (aHNE) or alkynyl-ONE (aONE), and adducted proteins were selectively conjugated 
to an azido-biotin tag containing a UV-cleavable linker (Figure 11). Tagged proteins were then 
captured on streptavidin beads, and the UV-cleavable linker in the biotin tag enabled elution of the 
adducted proteins following exposure to UV light. This eliminated the need for boiling samples to 
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dissociate them from the streptavidin beads, and led to a substantial decrease in background. The 
approach identified 1119 proteins in RKO cells that were targets of aHNE and/or aONE. 
  
 
One striking feature of the adduct inventory generated by Codreanu et al.84 was the 
differential target specificity between aHNE and aONE. Of 1119 adducted proteins, only 595 were 
targeted by both electrophiles. There were 252 proteins that were only targets of aONE, and 272 
proteins that were only adducted by aHNE. These large differences in protein susceptibility may 
be attributed to the relative reactivity of HNE and ONE to different amino acids. When the protein 
Figure 11. Click chemistry with a photo-cleavable biotin. Adducted proteins are conjugated to a UV-cleavable N3-
biotin under standard click chemistry conditions. After binding to streptavidin bead and washing to remove 
nonspecific binding, adducted protein can be selectively eluted with exposure to 365 nm UV light. 
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inventories were further investigated, a distinct difference in the nuclear targets of adduction was 
noted. Specifically, histone proteins, which are rich in Lys residues, were major targets of aONE 
adduction, whereas other chromatin-associated proteins, such as histone acetyl transferases that 
lack Lys and have multiple Cys and His residues, were targets of aHNE. These stark differences 
in protein targets highlight the importance of electrophile reactivity to specific nucleophilic targets 
and provide new avenues for the investigation of the functional implications of these adducts. 
 
Site-Specific Detection of Protein Adducts 
 The proteomic inventories described above have provided a wealth of knowledge on the 
protein targets of HNE and ONE in the cell, but the approaches employed did not allow for 
determination of the specific residue adducted within each protein. Site-specific detection of 
adducts remains a challenge at the proteome-wide scale. A newer method, developed in Benjamin 
Cravatt’s laboratory to investigate Cys targets of HNE in cells, employs a TEV-cleavable, 
isotopically labelled iodoacetamide-alkyne probe to modify free reactive Cys (Figure 12).2 Cys 
residues adducted with HNE are not tagged with the probe. Click chemistry is then performed to 
biotinylate tagged proteins, which are then isolated with avidin capture. Captured proteins are 
digested with trypsin, followed by TEV protease to release the tagged peptides for proteomic 
analysis. The loss of a peptide with increasing concentrations of HNE suggests that the Cys in the 
peptide is a site of HNE modification.   
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While this approach allows for a larger scale analysis of adduction sites, it is far from 
comprehensive. First, since the method only targets Cys residues, adducts of His and Lys are not 
detected. Second, this approach does not directly interrogate the HNE adduct, but rather implies 
an adduct with the loss of a reactive Cys residue. Finally, the method lacks specificity for any 
particular electrophile. Despite the fact that it is based on a concentration-dependence relationship 
with bolus addition of exogenous electrophile, a large number of additional electrophiles may be 
generated during the oxidative stress response to the toxicity of the exogenous electrophile 
exposure. Therefore, while adduction of specific Cys residues can be identified with this technique, 
the exact identity of the adducting species remains uncertain. 
 A direct, global approach was developed by Yang et al.{Yang, 2015 #526} In this method, 
cells are treated with aHNE and click chemistry is performed with isotopically labelled, 
photocleavable azido-biotin. Adducted proteins can be isolated and tandem mass spectrometry 
used to determine the sites of adduction and the amount of each modified residue. This approach 
Figure 12. Activity-based protein profiling for determination of HNE-adducted Cys. Reprinted by permission from 
Macmillan Publishers Ltd: Nature Protocols Weerapana et al. (2010) Nature 468:790-5. Copyright 2010.2  
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has large advantage in that it directly maps the precise site of adduction, as opposed to the indirect 
mapping in the Cravatt approach. The drawbacks of this method is that it does not detect all sites 
of adduction. While the proteomic inventory shows >1000 proteins as targets of aHNE adduction, 
only ~400 residues were identified as specific sites of adduction.  
Currently, the most comprehensive means to identifying specific sites of modification is 
by mass spectrometric analysis of recombinant, immunoprecipitated, or otherwise purified protein. 
For example, recombinant protein may be adducted in vitro with electrophile, reduced with 
NaBH4, digested with trypsin, and analyzed by mass spectrometry. The identified peptides can 
then be searched with the possible mass shifts for each residue of interest. Variations of this method 
can be applied to proteins immunoprecipitated from cells treated with HNE. In this case, utilizing 
overexpressed tagged cDNA constructs facilitates isolation of the protein of interest and provides 
larger amounts of material for analysis.87 Recently, Galligan et al.88 utilized a proteomic approach 
to identify specific sites of adduction on histones. Chromatin from cells treated with ONE was 
extracted with a high salt buffer, providing an extract that was highly enriched with histones. The 
proteins were separated by SDS-PAGE and in-gel digested for proteomic analysis, leading to the 
discovery of the 4-ketoamide adduct on histones. 
 The identification of adducts at specific residues remains a challenge in the field. The best 
method to determine sites of adduction requires pure proteins, or low complexity protein isolates, 
coupled with exhaustive computational searches for possible adducts and manual validation of 
adducted peptides. While very labor-intensive and low-throughput, this is the most comprehensive 
approach to adduct discovery and insight into the possible impact that adducts may have on protein 
function. 
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Cellular Implications of Protein Adduction by Lipid Peroxidation Products 
Antioxidant Responses to Oxidative Stress and Lipid Electrophiles 
Oxidative stress and lipid peroxidation can be particularly damaging to the cell, but a 
number of pathways and antioxidant mechanisms have evolved to combat toxic insults that can 
arise. The primary function of these various antioxidant pathways is to convert the reactive 
molecules to less reactive metabolites. Enzymatic antioxidants that work directly to remove 
oxidants from the cell have various levels of specificity toward their substrates. As described 
above, SOD acts specifically on O2·– to form H2O2 and O2, and expression of protein isoforms in 
different subcellular locations contributes to cellular defense.89 Similarly, catalase converts H2O2 
produced by SOD to H2O and O2, thereby preventing the formation of the more harmful HO· via 
the Fenton reaction.90 There are many less specific antioxidant enzymes that act on a range of 
exogenous and endogenous oxidants. An example is the glutathione peroxidase family that reduces 
organic hydroperoxides to their corresponding alcohols.91 
Many antioxidant enzymes, such as glutathione peroxidases, utilize glutathione as a 
cofactor for detoxification. Glutathione (GSH) is an endogenously generated small molecule that 
has the primary function of protecting cellular components. The action of GSH as both a 
nucleophile and a reductant contributes to the detoxification of reactive electrophiles and ROS.92 
While most of these defense mechanisms are present under basal conditions, regulation at the gene 
expression level can increase their availability in response to exposure to toxicants such as HNE 
and ONE in an attempt to maintain homeostasis.  
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Gene Expression Alterations 
 West and Marnett93 were the first to exhaustively explore global gene expression 
alterations in response to exogenous HNE exposure. At sub-cytotoxic concentrations of HNE, 
significant changes in gene expression were only observed in antioxidant response element- 
(ARE)-regulated genes. These genes are upregulated in response to oxidative stress conditions, 
including electrophile exposure. The encoded proteins assist in detoxifying oxidant-dependent 
reactive species in the cell by multiple mechanisms, including synthesis of GSH and maintenance 
of protein structure. Cytotoxic levels of HNE induced significant alterations in the heat shock, ER 
stress, and nutrient deprivation responses in addition to ARE upregulation. 
 Further investigations utilizing RNA-Seq demonstrated an even larger number of gene 
expression changes in response to HNE exposure.94 Genes associated with glutathione metabolism, 
cell cycle regulation, pyrimidine metabolism, and MAPK signaling were overrepresented in the 
dataset, due to large expression changes in those pathways. These data also revealed changes in 
transcript isoforms. In one example, the protein NEDD4 has two highly expressed transcripts, one 
protein-coding and the other noncoding. HNE treatment resulted in a significant decrease in the 
protein-coding transcript, while the noncoding transcript remained unchanged. Thus, the data 
revealed HNE-dependent gene expression regulation on multiple levels, and suggested the 
interesting possibility that alterations in chromatin or transcription factors and transcriptional 
machinery may contribute to the observed isoform switches.  
 
Disruption of Cell Signaling Pathways by Electrophile Adduction 
Electrophiles have the ability to modulate gene expression by direct adduction of 
transcription factors or their regulatory proteins, thereby altering transcription factor binding to the 
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target cis-regulatory regions. For example, electrophiles can activate the ARE and electrophile 
response element (EpRE) to increase transcription of genes encoding phase II detoxifying 
enzymes,95,96 regulate expression of heat shock proteins to maintain protein structure during 
oxidative stress, or inhibit additional pro-inflammatory responses.  
Electrophile stress is mainly sensed through the Kelch-like ECH-Associated Protein 1 
(Keap1) and the associated Nuclear Factor (Erythroid Dervied-2)-like 2 (Nrf2) pathway. Under 
normal conditions, cytosolic Keap1 binds to Nrf2 and promotes its degradation via cullin-3-
dependent ubiquitination and proteasomal degradation.97,98 Under conditions of oxidative stress, 
oxidants and lipid electrophiles modify Cys residues on Keap1, resulting in dissociation of Nrf2. 
The reduction in Nrf2 degradation results in increased levels and its accumulation in the 
nucleus.99,100 There, Nrf2 forms heterodimers with Maf proteins and other transcription factors to 
activate ARE-dependent gene expression.101 Target genes include heme oxygenase,102 glutathione 
S-transferases,103 glutamate-cysteine ligase,104 and others.105 
 Heat shock proteins (HSPs) inhibit protein aggregation and oxidation as well as assist in 
protein translocation by acting as molecular chaperones.106 Expression of HSPs is predominantly 
regulated by the transcription factor, heat shock factor 1 (HSF1). Under normal conditions, HSF1 
is localized in the cytosol where it interacts with HSP90 and HSP72, a member of the Hsp70 
family.107,108 Electrophile adduction or oxidation of HSP90 and HSP72 results in dissociation of 
the complex, HSF1 translocation to the nucleus, trimerization, phosphorylation, and binding to 
heat shock response elements.109 HNE has been shown to adduct Cys572 of HSP90 and Cys267 
of HSP72. Both of these modifications inhibit chaperone activity.110,111 HSF1 binding to heat shock 
response elements induces transcription of HSPs to maintain protein homeostasis and promotes 
BAG3 expression to inhibit apoptosis.112,113  
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Regulation of NF-kB, a transcription factor that modulates inflammatory gene 
transcription, by electrophiles has been extensively investigated due to the association of 
oxidatives stress with inflammation. Under normal conditions, NF-kB remains in the cytosol, 
bound to its inhibitor, IkB. IkB kinase (IKK) is activated in response to pro-inflammatory stimuli 
and phosphorylates IkB, resulting in its ubiquitination and proteasomal degradation. In the absence 
of IkB, NF-kB accumulates and translocates to the nucleus where it induces transcription of pro-
inflammatory cytokines, chemokines, and enzymes. HNE adduction has been shown to be 
inhibitory to NF-kB activation, both indirectly and directly. Indirectly, HNE adducts the conserved 
Cys179 on the activation loop of IKKb, contributing to IKK inhibition, stabilization of IkB, and 
retention of NF-kB in the cytosol.114 A similar, indirect inhibitory mechanism has been proposed 
for 15-deoxy-D12-14-prostaglandin J2 (15dPGJ2), an electrophilic metabolite of prostaglandin D2.115 
15dPGJ2 was also shown to inhibit NF-kB directly by adduction of Cys38 on the DNA-binding 
domain of the transcription factors p65 subunit, thereby contributing to loss of transcriptional 
activity.116   
 
Dissertation Aims 
 The main objective of this dissertation is to better understand the direct effects of protein 
adduction by HNE and ONE. Years of work have been dedicated to developing chemical tools to 
identify the targets of these electrophiles. However, this work has provided to us a massive 
proteomics library and gene expression data that require a more in-depth investigation into specific 
pathways of interest.  
 Chapter II describes investigations of a key cell cycle protein that is adducted by HNE. I 
was able to show that adduction of this protein occurs at multiple sites in vitro and in cells and 
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results in kinase inactivation and cell cycle inhibition. Chapter III explores the inactivation of the 
isomerase Pin1 by an ONE cross-link and proposes a mechanism of cross-link formation. A 
computational analysis based on this mechanism identifies additional proteins that may be cross-
linked by ONE. Chapter IV presents a novel method, Click-Seq, for the isolation of DNA 
associated with adducted histones. We developed this method to investigate the site-specificity of 
these chromatin modifications in the genome, which can provide information as to potential gene 
expression alterations that may occur in response to histone modification. Histone adducts are 
shown to be long-lived, suggesting they may impact gene expression and chromatin condensation. 
Levels of the 4-ketoamide adduct on Lys residues were comparable to low-abundance canonical 
histone modifications, suggesting that these adducts may have biological significance. 
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CHAPTER II 
 
COVALENT MODIFICATION OF CDK2 BY 4-HYDROXYNONENAL AS A 
MECHANISM OF INHIBITION OF CELL CYCLE PROGRESSION 
 
Reproduced with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 29(3):323-32. 
Copyright 2016 American Chemical Society.6 
 
Introduction 
Oxidative stress results from an imbalance between reactive oxygen species (ROS) 
generation and the antioxidant defenses of the cell and is a contributing factor in a number of 
diseases, including cancer, atherosclerosis, neurodegenerative disease, and asthma.70,117-119 ROS 
elicit their deleterious effects via reactions with cellular biomolecules, including proteins, DNA, 
and polyunsaturated fatty acids (PUFAs).120 The oxidation and subsequent decomposition of 
PUFAs result in the formation of reactive lipid aldehydes, such as 4-hydroxy-2-nonenal (HNE).47 
These lipid electrophiles are capable of forming covalent adducts with nucleophilic residues on 
proteins (i.e. Cys, His, and Lys), often proving detrimental to protein function.66,121 
 Cell cycle progression is a tightly controlled process involving a network of signaling 
events required to maintain genomic fidelity and prevent aberrant cell growth. CDK2 regulates the 
transition from G1 to S-phase and progression through S-phase via interactions with temporally 
expressed cyclin partners at different phases in the cell cycle.122,123 The interaction between CDK2 
and Cyclin E in late G1-phase results in hyperphosphorylation of Rb, a main tumor suppressor 
responsible for inhibiting DNA replication. This hyperphosphorylation causes the complete 
dissociation of the Rb/E2F1 complex, allowing for E2F1-mediated expression of S-phase genes 
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and entry into S-phase.124 During this time, Cyclin A is expressed, further modulating CDK2 
activity, so Rb remains hyperphosphorylated throughout S-phase. Under DNA damage conditions, 
Rb remains hypophosphorylated and bound to E2F1, thereby inhibiting cell cycle 
progression.125,126,127 The result is G1 arrest until the damage is repaired and the inhibitory signals 
are removed or the cell undergoes apoptosis. 
Previous studies have investigated the role of lipid peroxidation products, specifically 
HNE, in the regulation of the cell cycle.128 Early studies in S. cerevisiae revealed that treatment 
with HNE inhibits cells from entering S-phase, suggesting a defect at the G1/S restriction point, 
and further studies in mammalian cells have yielded similar results.129 Treatment of human 
leukemia and neuroblastoma cell lines with HNE led to a halt in the cell cycle at G0/G1, by both 
p53-dependent and independent mechanisms.130,131 In the p53 wild-type neuroblastoma cell line, 
SK-N-BE, HNE increased levels of p53 and p21 after a 24 h treatment, resulting in G1 arrest. In 
the p53-deficient leukemic cell line, HL-60, a rapid decrease in Rb phosphorylation coupled with 
an increase in Rb/E2F1 complexes following HNE treatment is indicative of G1 arrest. In those 
cells, p21 was not induced until 12 h following HNE treatment, suggesting that a more immediate 
inhibition of G1-phase CDKs allowed for the maintenance of intact Rb/E2F1 complexes through 
suppression of Rb hyperphosphorylation.  
 While these previous studies demonstrate a role for HNE in cell cycle inhibition, the precise 
mechanism leading to this inhibition remains unclear. Recently, we have utilized alkynyl HNE 
(aHNE), the w-alkyne analog of HNE, to identify adducted cellular proteins. aHNE maintains the 
reactivity of HNE in cells, and it allows for post-hoc biotinylation using click chemistry to 
selectively isolate modified proteins.86,5 Proteomic analysis identified CDK2 as a target of aHNE, 
and adduction increased with increased electrophile concentration linearly over the concentrations 
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studied.84 Gene expression data from HNE-treated RKO cells provided further insight into 
pathways significantly altered by HNE treatment. A systems analysis approach that integrates 
proteomic and gene expression data revealed that treatment of cells with HNE not only results in 
modification of CDK2, but leads to significant decreases in the genes controlled by CDK2 
activation.132 These data suggest that HNE modification of CDK2 could result in cell cycle arrest 
at the G1/S-phase transition. Here, we show that modification of recombinant CDK2 by HNE 
disrupts its kinase activity. We identify the major sites of HNE-mediated CDK2 modification and 
use aHNE to define the time course of CDK2 adduction in cells. We further show that HNE inhibits 
CDK2 activity in intact cells, suggesting that HNE-mediated CDK2 kinase inactivation is a direct 
contributor to cell cycle disruption. Finally, we show that HNE delays entry into S-phase by a 
mechanism that does not depend on induction of p53 or p21, supporting a role for CDK2 
inactivation in that process. 
 
Materials and Methods 
Materials and Reagents. All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless 
otherwise stated. HNE, 8,9-alkynyl-HNE (aHNE), and UV-cleavable azido-biotin were 
synthesized in the laboratory of Dr. Ned Porter at Vanderbilt University as previously described.5 
Cell culture medium and 1X Dulbecco’s Phosphate Buffered Saline (DPBS, pH 7.2) was 
purchased from Invitrogen (Grand Island, NY). Fetal bovine serum (FBS) was obtained from Atlas 
Biologicals (Ft. Collins, CO). Recombinant CDK2 protein was purchased from Abcam 
(Cambridge, MA), and CDK2-Cyclin E and CDK2-Cyclin A recombinant complexes were 
purchased from EMD Millipore (Billerica, MA). Anti-CDK2 (M2), anti-actin, and Protein A/G 
Plus Agarose Beads were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-pT160 CDK2 
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and anti-PARP antibodies were from Cell Signaling Technologies (Danvers, MA). Anti-cyclin E1 
[HE12], anti-p27 KIP1, anti-Rb (phospho T821), anti-cyclin A2 [E23.1], and anti-p21 antibodies 
were purchased from Abcam. All SDS-PAGE and western blot supplies were obtained from Bio-
Rad (Hercules, CA) unless otherwise noted. Streptavidin Sepharose High Performance beads, γ-
32P-ATP, calf histone H1 protein, and dithiothreitol (DTT) were purchased from GE Life Sciences 
(Pittsburg, PA), PerkinElmer (Santa Clara, CA), EMD Millipore, and Research Products 
International (Mt. Proscpect, IL), respectively. 
 
Cell Culture and Treatments. The human colorectal cancer cell line, RKO, was obtained from 
American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) with 10% FBS at 37°C with 5% CO2. Electrophiles were 
dissolved in DMSO and added to cell culture medium with a final concentration of less than 0.1% 
DMSO. Concentrations of HNE used in the studies were not cytotoxic as a result of the limited 
length of exposure and the high concentrations of glutathione in RKO cells.133,84 
 
Flow Cytometry for Cell Cycle Analysis. Cells were serum-starved for 24 h to synchronize in 
G1/G0. Cells were then pretreated with 30 µM HNE or DMSO for 1 h in serum-free medium 
followed by release into medium containing 10% FBS and harvest at the indicated times. During 
collection, cells were washed with 1X DPBS (pH 7.2), trypsinized, and washed a second time with 
1X DPBS. Cells were fixed with ice-cold absolute ethanol overnight at -20°C, then collected by 
centrifugation at 1000 x g for 5 min and washed twice with 1X DPBS. Following resuspension in 
1 ml 1X DPBS, samples were incubated at 37 °C for 15 min with 50 µl of 1mg/ml RNase A, cooled 
to room temperature (RT) and stained with propidium iodide at a final concentration of 20 µg/ml. 
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Samples were stored at 4°C in the dark and analyzed on a 3-laser BD LSRII flow cytometer (BD 
Biosciences, Franklin Lakes, NJ). 
 
Protein Extraction. Cells were scraped into medium, collected by centrifugation at 500 x g for 5 
min, and washed twice with 1X DPBS. Cells were lysed for 10 min on ice in RIPA buffer [50 mM 
Tris (pH 7.4), 150mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 1mM EDTA] 
containing protease and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO) and centrifuged at 
16,000 x g for 20 min. The supernatant was collected, and the pellet was discarded. The BCA assay 
was used to determine protein concentrations according to manufacturer’s protocol (Thermo 
Fischer Scientific, Waltham, MA). 
 
Click Chemistry. Cell lysates (1 mg protein) were reduced with 20 mM NaBH4 and subjected to 
click chemistry according to a previously described method.84 Briefly, the lysates were incubated 
with 1 mM CuSO4, 1 mM tris(2-carboxyethyl)phosphine, 0.1 mM 
tris(benzyltriazolylmethyl)amine, and 0.2 mM UV-cleavable azido biotin for 2 h at RT with end-
over-end mixing. Protein was precipitated with 2 volumes of ice-cold methanol and resolubilized 
in 0.5% SDS with sonication and mixing. Streptavidin beads were added overnight at 4 °C in the 
dark with end-over-end mixing, washed twice each with 1% SDS, 4 M urea, 1 M NaCl in 1X 
DPBS, and 1X DPBS, and adducted proteins eluted in water under 365 nm UV light for 90 min. 
Eluates were dried under nitrogen and resuspended in water. 
 
SDS-PAGE and Western Blots. Samples were denatured in 2X Laemmli sample buffer with 5% β-
mercaptoethanol and heated at 95°C for 5 min. Proteins were resolved by SDS-PAGE and 
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transferred onto nitrocellulose membranes. Membranes were blocked in Odyssey Blocking Buffer 
(Li-Cor Biosciences, Superior, NE) for 1 h at RT, and primary antibodies were applied overnight 
at 4 °C in Odyssey Blocking Buffer. Membranes were washed three times in tris-buffered saline 
with Tween-20 (TBST), and infrared secondary antibodies (Li-Cor) were added at a 1:5000 
dilution for 1 h at RT. Following three additional washes, blots were developed using the Odyssey 
Infrared Imaging System (Li-Cor). 
 
In-Solution Modification of Recombinant CDK2. Recombinant CDK2 protein was diluted to 2.5 
mg/ml in 1X DPBS.  HNE (30 µM) or DMSO (vehicle control) was added to the pure protein at 
the indicated concentrations and incubated for 1 h with gentle agitation at 37 °C.  The reaction 
mixture was quenched with the addition of NaBH4 to a final concentration of 20 mM, reduced with 
150 µM DTT for 30 min at 37 °C, and alkylated with 750 µM iodoacetamide for 15 min at RT in 
the dark. Samples were digested with 10 ng/µl trypsin overnight and dried by vacuum 
centrifugation. 
 
Generation of CDK2-His. Cdk2-HA was a gift from Sander van den Heuvel (Addgene plasmid 
#1884).134 Cdk2 was PCR-amplified with the following primers to replace the C-terminal HA-tag 
with a C-terminal 6XHis-tag: forward 5′- CATCATGGATCCATGGAGAACTT-3′, reverse 5′- 
TTATGAATTCTATCAATGGTGATGGTGATGGTGGAGTCGAAGATGGGGTA-3′. The 
PCR product was digested with BamHI and EcoRI and ligated into pcDNA3.1 (Invitrogen) for 
expression in mammalian cells (pcDNA3.1-CDK2-6XHis). 
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Transfection and Purification of CDK2-His. RKO cells were transfected with pcDNA3.1-CDK2-
6XHis (10 µg) with 10 µl Lipofectamine 2000 (Invitrogen) in Opti-MEM medium for 24 h, then 
medium replaced with serum-free DMEM containing 250 µM HNE for 1 h. Cells were scraped in 
cold 1X DPBS and lysed on ice in His Lysis Buffer [50 mM sodium phosphate (pH 8.0), 300 mM 
NaCl, 20 mM imidazole, and 0.05% Tween-20] for 10 min. Lysates were cleared by centrifugation 
at 16,000 x g for 10 min. Lysates were reduced with 20 mM NaBH4 for 15 min to stabilize adducts. 
Ni-NTA beads (Qiagen) were added to lysates and incubated with end-over-end mixing for 2 h at 
4 °C. Beads were washed six times with His Lysis Buffer then eluted with His Elution Buffer [50 
mM sodium phosphate (pH 8.0), 300 mM NaCl, 250 mM imidazole, and 0.05% Tween-20] for 5 
min at RT. Eluates were denatured in 2X Laemmli sample buffer with 5% β-mercaptoethanol, 
heated at 95°C for 5 min, and proteins were resolved by SDS-PAGE. Following staining with 
Simply Stain (Invitrogen), bands corresponding to CDK2-His were excised and cut into 1 mm3 
pieces. Gel pieces were treated with 45 mM DTT for 45 min and carbamidomethylated with 100 
mM iodoacetamide for 45 min. Following destaining with 50% acetonitrile in 25 mM ammonium 
bicarbonate, 10 ng/µL trypsin was added overnight at 37 °C. Peptides were extracted by gel 
dehydration (60% acetonitrile, 0.1% TFA) and dried by vacuum centrifugation. 
 
Analysis of CDK2 Peptides by LC-MS/MS. Following reconstitution in 0.1% formic acid, peptides 
were loaded onto a capillary reverse phase analytical column (360 µm O.D. x 100 µm I.D.) using 
an Eksigent NanoLC Ultra HPLC and autosampler. The analytical column was packed with 20 cm 
of C18 reverse phase material (Jupiter, 3 µm beads, 300 Å, Phenomenox), directly into a laser-
pulled emitter tip. Peptides were gradient-eluted at a flow rate of 500 nL/min, and the mobile phase 
solvents consisted of 0.1% formic acid, 99.9% water (solvent A) and 0.1% formic acid, 99.9% 
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acetonitrile (solvent B).  A 90 min gradient was performed, consisting of the following:  0-10 min, 
2% B; 10-50 min, 2-40% B; 50-60 min, 35-95% B; 60-65 min, 95% B, 65-70 min 95-2% B, 70-
90 min, 2% B.  Upon gradient elution, peptides were mass analyzed on a Thermo Scientific LTQ 
Orbitrap Velos mass spectrometer, equipped with a nanoelectrospray ionization source. The mass 
spectrometer was operated using a data-dependent method with dynamic exclusion enabled. Full 
scan (m/z 300-2000) spectra were acquired with the Orbitrap as the mass analyzer (resolution 
60,000), and the ten most abundant ions in each MS scan were selected for fragmentation in the 
LTQ. An isolation width of 2 m/z, activation time of 10 ms, and 35% normalized collision energy 
were used to generate MS2 spectra.  For identification of modified peptides, tandem mass spectra 
were searched with Sequest against a human database created from the UniprotKB protein 
database (www.uniprot.org). Variable modifications of +57.0214 on Cys (carbamidomethylation), 
+15.9949 on Met (oxidation), +158.1306 on Cys, His, and Lys residues (corresponding to the 
reduced Michael adduct of HNE), +141.1279 on Lys and Arg (corresponding to the reduced Schiff 
base adduct of HNE), and +156.1150 on Lys (corresponding to the 4-ketoamide adduct) were 
included for database searching. Search results were assembled using Scaffold 3.0 (Proteome 
Software), and sites of modification were validated by manual interrogation of tandem mass 
spectra. 
 
In vitro Modification of CDK2 for Activity Assays.  Recombinant CDK2 complexed with Cyclin E 
or Cyclin A (15 ng) was incubated with 30 µM HNE in Kinase Assay Buffer [20 mM HEPES (pH 
7.4), 10 mM MgCl2] at 37 °C for 1 h with gentle agitation. Samples were immediately subjected 
to in vitro kinase assays as described below.    
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CDK2 Immunoprecipitation. Immunoprecipitations were performed according to a previously 
established protocol.135 Briefly, 800 µg total cell lysate protein was immunoprecipitated using anti-
CDK2 antibodies on ice for 3 h then for 90 min with protein A/G agarose beads with end-over-
end mixing. CDK2-bound beads were collected and washed three times with RIPA buffer followed 
by three washes with Kinase Assay Buffer containing 1 mM DTT. Beads were resuspended in 
Kinase Assay Buffer containing 1 mM DTT and subjected to western blotting or kinase assays. 
 
In vitro Kinase Assays. Kinase assays were adapted from previous methods.135 Histone H1 protein 
(2 µg), 50 µM unlabeled ATP, 10 µCi γ-32P-ATP, and Kinase Assay Buffer containing 1 mM DTT 
were added to a final volume of 50 µl for in vitro modified samples and 25 µl for CDK2 
immunoprecipitates. The reactions were incubated at RT for 20 min with shaking and stopped with 
the addition of 2X Laemmli sample buffer with 5% β-mercaptoethanol. Samples were heated at 
95 °C for 10 min, cooled, and loaded onto a 4-20% polyacrylamide gel. Following electrophoresis, 
radioactive histone H1 protein was detected with the Molecular Imager PharosFX System 
(BioRad, Hercules, CA). Images were quantitated with ImageJ (NIMH, Bethesda, MD). The gel 
was then stained with Simply Stain (Invitrogen) according to the manufacturer’s protocol. 
 
Results 
HNE modifies a number of sites on recombinant CDK2 
To elucidate possible structural and functional implications of CDK2 adduction, the sites of 
modification were determined by tandem mass spectrometry. Recombinant CDK2 was modified 
in vitro with HNE, digested, and analyzed by LC-MS/MS. There were a number of peptides that 
showed a mass shift of 158.1306 m/z, corresponding to a reduced Michael adduct, following HNE 
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treatment (Table 1). When sites of modification were mapped on a previously established crystal 
structure of CDK2 (1HCL), adducted sites were mainly localized to surface-exposed His residues 
(Figure 13). Of note, His71 and His161 were modified by HNE. His71 lies on the cyclin-binding 
interface and hydrogen bonds with residues on both Cyclin E and Cyclin A. His161 immediately 
follows Thr160, the key CDK2 phosphorylation site required for kinase activity.  
 
Peptide Residue Modified XCorr
Observed 
m/z Charge
Mass 
Error 
(ppm)
Peptide
Start-
Stop
Observed 
Spectra
ELNH*PPNIVK His60 3.15 611.3672 2 0.33 57-65 3
LLDVIH*TENK His71 3.12 670.3999 2 0.15 66-75 4
DLK*PQNLLINTEGAIK Lys129 3.55 642.3870 3 0.00 127-142 2
TYTH*EVVTLWYR His161 3.18 863.4668 2 0.17 158-169 8
SLLSQMLH*YDPNKR His268 3.45 620.6743 3 0.32 261-273 2
AALAH*PFFQDVTK His283 2.13 534.9724 3 0.37 279-291 7
PVPH*LR His295 1.89 438.7900 1 1.82 292-298 4
Table 1. Sites of HNE modification on recombinant CDK2 identified by LC-MS/MS. Recombinant CDK2 was 
modified in vitro with 30 µM HNE and analyzed for sites of HNE adduction by tandem mass spectrometry in three 
independent experiments. Modified residues are indicated by an asterisk. Data shown in the table represent the 
adducted peptides with the lowest mass error. Reproduced with permission from Camarillo et al. (2016) Chem. Res. 
Toxicol. 29(3):323-32. Copyright 2016 American Chemical Society.6 
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HNE modified CDK2 in RKO cells 
As noted above, prior work had demonstrated HNE-dependent CDK2 modification in the RKO 
colorectal cancer cell line.84 To verify the sites of CDK2 modification in cells, we transfected RKO 
cells with a His-tagged CDK2 construct, then treated the cells with HNE. Following isolation of 
His-tagged protein, we performed in-gel digestion and analyzed the peptides by LC-MS/MS (Table 
2). As in the case of recombinant CDK2, His71 was identified as a site of modification (Figure 
14A). Interestingly, Cys177 was also modified by HNE in cells (Figure 14B). This modification 
His71	
His161	
His60	
His268	
Lys129	
His283	
His295	
His71	
Cys177	
Cys177	
His161	
Lys129	
His60	
His268	
His283	
His295	
90° 
Figure 13. Recombinant CDK2 is modified by HNE at a number of sites. Crystal structure of unphosphorylated CDK2 
(PDB 1HCL) with residues modified by HNE in magenta. Reproduced with permission from Camarillo et al. (2016) 
Chem. Res. Toxicol. 29(3):323-32. Copyright 2016 American Chemical Society.6 
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has previously been observed in the literature,2 though we did not observe it in recombinant 
protein, possibly due to oxidation of that Cys residue during storage. 
 
 
Peptide Residue Modified XCorr 
Observed 
m/z Charge 
Mass 
Error 
(ppm) 
Peptide 
Start-
Stop 
Observed 
Spectra 
LLDVIH*TENK His71 3.58 670.3919 2 4.92 66-75 3 
APEILLGC*K Cys177 2.87 1101.6543 1 3.99 170-178 5 
 
Table 2. Sites of HNE modification on endogenous CDK2 identified by LC-MS/MS. RKO cells were transfected with 
CDK2-His and treated with HNE. Following isolation of His-tagged proteins and separation by SDS-PAGE, bands 
corresponding to CDK2-His were excised, subjected to in-gel digestion, and analyzed by tandem mass spectrometry. 
Modified residues are indicated by an asterisk. Data shown in the table represent the adducted peptides with the 
lowest mass error. Reproduced with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 29(3):323-32. 
Copyright 2016 American Chemical Society. 
 42 
 
300 400 500 600 700 800 900 1000 1100
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
Ab
un
da
nc
e
[MH-H2O]
1083.6953
b6
637.4341 y6
804.6099
b5
524.2642 y5691.5405
y4
578.3378
b8
955.6794
b4
411.2632 y8
1030.6735
A P E I L L G C* K
b5
y8 y4y6y5
b4 b6 b8
200 300 400 500 600 700 800 900 1000 1100 1200 1300
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
Ab
un
da
nc
e
[MH-NH3]
+2
661.6494
b9
1079.6422
y8
+2
557.4817
y7
+2
499.9123
y9
+2
614.0427
y8
1113.6398b6
849.5683
y2
261.1907 y5
786.5165 y6
899.5413
b3
342.2656 y7
998.6304
b4
441.2896 b7
950.5593
y5-NH3
769.4549
L L D V I H* T E N K
b3
y8 y7 y6y5 y2
b4 b7b6 b9
y9
A
B
Figure 14. CDK2 is modified by HNE in cells. Tandem mass spectrometry was performed on CDK2-His from HNE-
treated RKO cells. A) MS2 spectrum of LLDVIH*TENK. B) MS2 spectrum of APEILLGC*K. Sites of modification 
are represented by an asterisk (*). Reproduced with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 
29(3):323-32. Copyright 2016 American Chemical Society. 
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HNE-dependent modification of CDK2 temporally correlates with cell cycle arrest 
Since CDK2 is modified at a number of sites in vitro, we wanted to further verify its modification 
in cells and assess if CDK2 adduction by HNE could be contributing to previously observed cell 
cycle dysregulation. To determine if CDK2 is modified by HNE within the relevant time frame to 
alter the cell cycle, we employed the 8,9-alkynyl analog of HNE, aHNE, and used click chemistry 
to evaluate the levels of modified CDK2 in cells. RKO cells synchronized in G1/G0 were treated 
with aHNE or DMSO for 1 h and released into 10% serum-containing medium to allow for cell 
cycle progression. Click chemistry, streptavidin pull-down, and UV-cleavage enabled selective 
isolation of adducted proteins. Western blot analysis of eluates showed persistent modification of 
CDK2 by aHNE up to 16 h (Figure 15). There was a decrease in adducted CDK2 over time, 
indicative of protein turnover or adduct reversal. These data show that CDK2 is modified rapidly 
in cells, and that the modification persists for a substantial time period, consistent with the 
hypothesis that the modification may lead to functional alterations affecting the role of CDK2 in 
cell cycle progression.  
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HNE treatment decreases kinase activity in CDK2/Cyclin A complexes in vitro 
CDK2 phosphorylates a number of proteins in late G1 to promote cell cycle 
progression.136,137,124,138 Since HNE has previously been shown to inhibit the activity of another 
protein kinase, ERK1/2,139 we sought to investigate the possible effects of HNE on CDK2 kinase 
activity. To assess the functional impact of HNE modification, we determined changes in CDK2 
kinase activity of recombinant CDK2-cyclin complexes following HNE exposure. CDK2/Cyclin 
E or CDK2/Cyclin A complexes were modified in vitro with HNE and subjected to radioactive 
Figure 15. aHNE modifies CDK2 in RKO cells. RKO cells were serum starved for 24 h to synchronize them in G0/G1, 
then treated for 1 h with 30 µM aHNE or DMSO. Treatment medium was removed, and 10% serum-containing 
medium was added to allow the cells to enter into the cell cycle. Cells were collected at the indicated times and lysates 
subjected to click chemistry and streptavidin pull down. UV eluates and 1% input were subjected to SDS-PAGE and 
western blot. A) Western blot shows levels of aHNE-modified CDK2 decline over time after initial treatment, while 
levels of total CDK2 remain unchanged. B) Densitometry of adducted CDK2 normalized to the 0 h eluate. Reproduced 
with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 29(3):323-32. Copyright 2016 American Chemical 
Society.6 
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kinase assays using histone H1 as a model substrate.135 As shown in Figure 16A, there was a 
significant decrease in histone H1 phosphorylation in CDK2/Cyclin A complexes (Figure 16B) 
treated with 30 µM HNE, but not in CDK2/Cyclin E complexes, which exhibited a trend towards 
decreased activity that was not statistically significant (Figure 16C). These differences in the 
effects of HNE on CDK2 activity in the two complexes may be the result of structural differences 
in the way that each cyclin interacts with CDK2. Regardless of the mechanism, these data confirm 
that HNE modification can directly alter CDK2 activity. 
 
 
Figure 16. HNE treatment lowers CDK2 activity in vitro. Recombinant CDK2 protein with Cyclin A or Cyclin E was 
modified in vitro with 30 µM HNE. A) Kinase assays followed by autoradiography show an HNE-mediated decrease 
in CDK2 activity with Cyclin A but not Cyclin E. Quantification of CDK2 activity with B) Cyclin A and C) Cyclin E 
representing the mean ± S.D. (n=3), *, p < 0.05. Reproduced with permission from Camarillo et al. (2016) Chem. 
Res. Toxicol. 29(3):323-32. Copyright 2016 American Chemical Society.6 
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HNE treatment decreases CDK2 activity in cells 
To further investigate the functional implications of HNE adduction of CDK2 in the cell, we 
performed in vitro kinase assays utilizing endogenous CDK2-cyclin immunoprecipitates. Cells 
were arrested in G1 with serum-starvation, treated with HNE for 1 h, then released into the cell 
cycle with the addition of medium containing 10% FBS. Cells were lysed and CDK2-cyclin 
complexes captured at various time points up to 12 h thereafter. As shown in Figure 17, 
phosphorylation of histone H1 was low in CDK2-cyclin immunoprecipitates isolated from cells 
harvested immediately following treatment with HNE (lanes 1 and 2). Kinase activity has 
substantially increased by 6 h, but there is little difference in H1 phosphorylation between the 
control and HNE-treated cell immunoprecipitates until 8 h following release. At 8 h (lanes 5 and 
6), HNE-treated CDK2 immunoprecipitates display significantly lower levels of kinase activity 
(Figure 17B). These data suggest that HNE treatment lowers the activity of CDK2 in a time-
dependent fashion, possibly contributing to the delay in cell cycle progression. 
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HNE delays entry into S-phase 
Previous reports have shown that HNE inhibits cell growth via multiple mechanisms.140,141,131 To 
further elucidate the mechanism of inhibition, RKO cells were synchronized in G1/G0 by serum 
withdrawal, treated with HNE, and then released from cell cycle arrest with serum-containing 
medium. As expected, cell cycle analysis showed a high percentage of cells arrested in G0/G1 
Figure 17. HNE treatment decreases CDK2 activity in cells. CDK2 was immunoprecipitated from RKO cells treated 
with HNE and subjected to kinase assays. A) CDK2 from cells treated with HNE shows a decrease in kinase activity 
at 8 h and 12 h. B) Quantification of CDK2 activity representing the mean ± S.D. (n=3). The difference in kinase 
activity was statistically significant at 8 h (*, p < 0.05) but not 12 h. Reproduced with permission from Camarillo et 
al. (2016) Chem. Res. Toxicol. 29(3):323-32. Copyright 2016 American Chemical Society.6 
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following serum starvation (Figure 18). After 8 h in serum-containing medium, cells treated with 
DMSO displayed an increase in the percent of cells in S-phase, while the percentage HNE-treated 
cells in S-phase remained significantly lower. Although increasing in both sets of cultures by 12 
h, the percentage of S-phase cells continued to be significantly lower in those exposed to HNE 
than in controls. However, these differences in the percent of cells in S-phase were abolished at 16 
h, suggesting that HNE-treated cells have a delay in S-phase initiation.   
 
 
HNE does not alter levels of total or phosphorylated cell cycle proteins 
We tested the hypothesis that alterations in the levels or phosphorylation state of one or more of 
the proteins involved in the G1/S transition could account for the HNE-mediated delay in S-phase 
entry. Western blot analysis did not reveal any differences in levels of total CDK2 in the presence 
or absence of HNE at the observed times (Figure 19). Phosphorylation of CDK2 at Thr160, which 
is required to activate CDK2 in G1-phase,142 also did not show any significant changes with 
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Figure 18. HNE delays entry into S-phase. RKO cells were serum-starved for 24 h to synchronize them in G0/G1, 
then treated for 1 h with 30 µM HNE or DMSO. Medium containing 10% serum was added to allow the cells to enter 
into the cell cycle. Cells were collected at the indicated times and cell cycle phase analyzed by flow cytometry. The 
data represent the mean ± S.D. (n=6; *, p<0.05 between HNE-treated and DMSO –treated, using one-way ANOVA 
with Bonferroni post-test). Reproduced with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 29(3):323-
32. Copyright 2016 American Chemical Society.6 
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treatment, nor did phosphorylation of Thr821 on Rb, a CDK2 target. Additionally, levels of Cyclin 
E and Cyclin A, both of which are required for CDK2 activity, were unchanged with treatment.  
 
 
 We further investigated levels of G1 inhibitory proteins to rule out inhibition of CDK2 by 
these damage pathways. HNE is known to activate the p53 response pathway, upregulate p21, and 
induce apoptosis via caspase and PARP cleavage.143 Levels of p53 did not increase over the 
observed times (Figure 19), consistent with previous reports showing that p53 is not upregulated 
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Figure 19. HNE does not alter levels of total or phosphorylated cell cycle proteins. RKO cells were serum-starved for 
24 h to synchronize them in G0/G1 then treated for 1 h with 30 µM HNE or DMSO. Medium containing 10% serum 
was added to allow the cells to enter into the cell cycle. Cells were collected at the indicated times and analyzed for 
expression of G1/S-phase proteins. Reproduced with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 
29(3):323-32. Copyright 2016 American Chemical Society.6 
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until 24 h following treatment.131 We also determined the levels of p21, which is canonically 
regulated by p53, but can also be induced in a p53-independent manner.144 Levels of p21 and p27, 
an additional G1 CDK inhibitor, remained unchanged in response to HNE, demonstrating that 
CDK2 is not being directly inhibited by this mechanism. Additionally, we did not observe PARP 
cleavage (data not shown), indicating that apoptosis was not being initiated during these observed 
times. Together, these data suggest that the observed delay into S-phase occurs independently of 
these S-phase inhibitory pathways. 
 
Discussion 
 Here, we investigated the impact of HNE modification on CDK2 function and cell cycle 
progression. Since CDK2 has previously been identified as a target of aHNE,84 we investigated 
the extent of CDK2 modification in RKO cells. Modified CDK2 was present up to 16 h following 
HNE exposure, though levels declined over time, consistent with turnover or reversal of adducts. 
Tandem mass spectrometry of HNE-treated recombinant CDK2 revealed a number of sites of 
modification (Table 1). The majority of adducts found were on surface-exposed His residues, 
likely due to their accessibility. A single Lys residue was also found to be modified, consistent 
with the lower reactivity of HNE toward Lys residues.64 While CDK2 does contain Cys residues, 
the preferred targets of electrophile modification, all but a single Cys is disulfide bound. When 
sites of modification were determined in cells, Cys177 was shown as a target of HNE modification, 
in addition to His71, which had been identified in vitro. Previous work by Weerapana et al.2 also 
demonstrated adduction of Cys177 by HNE, further supporting the validity of this modification. 
The data suggest that His71 and Cys177 represent the most readily accessible sites of modification 
in cells. 
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Of the seven modified residues, two appear to be in a location that could greatly impact 
CDK2 activity. Using published crystal structures of CDK2, we were able to model the HNE 
adducts on His71 (Figure 20A) and His161 (Figure 20B). His71 lies on the cyclin-binding 
interface. Crystal structures of CDK2 phosphorylated at Thr160 and in complex with Cyclin E or 
Cyclin A have revealed that His71 is capable of hydrogen bonding with both cyclins.145,146 As the 
CDK2-cyclin interaction is required for CDK2 activation, it is possible that disruption of this 
interaction could ultimately inhibit kinase activity. Consistently, we observe a reduction in the 
kinase activity of HNE-treated recombinant CDK2/Cyclin A complexes. In contrast, activity 
assays using recombinant CDK2/Cyclin E complexes did not show significant differences with 
HNE treatment. We hypothesize that these differences in the effects of HNE on CDK2/cyclin 
complex kinase activity result from the structural differences between Cyclin E and Cyclin A and 
their required points of contact with CDK2. The Cyclin A/CDK2 interaction requires two 
additional contact points with Thr72 and Gln73, both of which are not required for Cyclin E.146 
These subtle differences in structure may account for the functional differences observed. 
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This His161 HNE modification site is of significant interest due to its proximity to the 
activating phosphorylation site. Phosphorylation of Thr160 by CDK7/Cyclin H occurs in response 
to growth factor stimulation and results in a significant conformational change in the activation 
loop of CDK2.147 Previous studies have shown that adduction of a similar His residue on the 
activation loop of ERK1/2 results in decreased activity.139 Furthermore, Cyclin A is in contact with 
His161 in the active complex, and this interaction is not present in the complex with Cyclin E. 
These differences may contribute to the variances in HNE-mediated modification of kinase activity 
between CDK2/Cyclin A and CDK2/Cyclin E complexes in vitro. Notably, however, this site was 
not identified in intact cells, an observation that may correlate with the finding that HNE treatment 
had no effect on Thr160 phosphorylation of CDK2 in our model (Figure 19). Thus, it is not clear 
to what extent modification at this site may be important to the effects of HNE on cell cycle 
regulation in vivo. 
A B
Figure 20. Modeling of HNE adducts on CDK2. HNE adducts (magenta) were modeled onto A) His71 of CDK2 in 
the CDK2 (green) with Cyclin E (blue) structure (1W98) and B) His161 in the phosphorylated Thr160 structure of 
CDK2 (4EOM). Reproduced with permission from Camarillo et al. (2016) Chem. Res. Toxicol. 29(3):323-32. 
Copyright 2016 American Chemical Society.6 
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 Further evidence that HNE can negatively impact CDK2 signaling is shown in in vitro 
kinase assays. Activity assays using endogenous CDK2 from RKO cells show a decrease in histone 
H1 phosphorylation by immunoprecipitates from cells treated with HNE at 8 h. Due to temporal 
regulation of CDK2, activity of CDK2 is very low at 0 h, when the cells are arrested in G1, so no 
effect of HNE treatment is observed at that time. By 6 h, following addition of serum, substantial 
CDK2 activity could be measured, but no effect of HNE was observed. In contrast, at the 8 h time 
point a significant decrease in activity was observed between CDK2 immunoprecipitates recovered 
from control versus HNE-treated cells. Notably, the 8 h time point correlates when control, but not 
HNE-treated cells begin their progression into S phase. It is not clear why a reduction in CDK2 
activity is not observed at 6 h after HNE treatment; however, our in vitro assays demonstrate that 
the effects of HNE differ depending on the CDK2/Cyclin complex formed. Thus, changes in post-
translational modifications and/or binding partners during the CDK2 activation process may be 
responsible for these observed differences.  
 The most highly characterized substrate of CDK2 is Rb, phosphorylation of which 
inactivates its inhibitory effect on the E2F1 transcription factor. Thus, we expected to see that HNE 
treatment of RKO cells would result in a reduction of Rb phosphorylation at Thr821, a target site 
for CDK2. Although the data suggest a trend in reduced phosphorylation at 12 h and 16 h after 
serum addition, the differences were not statistically significant. It is possible that this lack of 
change in phosphorylation is the result of compensatory CDK4/6-dependent phosphorylation. 
While Thr821 is preferentially phosphorylated by CDK2,148 CDK4 has been shown to 
phosphorylate this residue.149 It is also possible that the immunoblot-based assay used lacked 
adequate sensitivity to observe a change. 
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 Our data build upon previous work on the effects of HNE on the cell cycle.128 Cell cycle 
analysis of G1/G0-synchronized RKO cells shows that HNE treatment delays entry into S-phase. 
Our data also show that this delay occurs in the absence of increases in the levels of p53, p21, and 
p27, suggesting that these inhibitory proteins do not play a primary role in initiating the failure to 
progress (Figure 19). We propose the following mechanism for CDK2 inhibition (Figure 21). 
Under normal conditions, CDK2 activation requires cyclin binding and phosphorylation of the 
activation loop. High levels of DNA damage promote activation of the p53 pathway, directly 
leading to the inhibition of CDK2 through the binding of p21. Our data suggest that covalent 
modification of CDK2 by HNE can immediately inhibit CDK2 activity. This mechanism of 
inactivation occurs via direct modification of CDK2 at multiple sites, thereby inhibiting kinase 
activity and delaying entry into S-phase. We hypothesize that CDK2 inactivation by adduction 
plays a role in the immediate cell cycle delay observed in response to HNE treatment, whereas 
p21, which is induced later, plays a longer-term role in the maintenance of genomic integrity 
during electrophile stress. 
 
 55 
  
Figure 21. Proposed mechanism for the delay in S-phase entry. Under normal conditions, Rb remains bound to E2F 
until the G1 CDKs phosphorylate it, allowing for transcription of S-phase genes. Our model suggests that HNE 
covalently modifies CDK2, decreasing its activity toward Rb, and delaying S-phase entry. Reproduced with 
permission from Camarillo et al. (2016) Chem. Res. Toxicol. 29(3):323-32. Copyright 2016 American Chemical 
Society.6 
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CHAPTER III 
 
SITE-SPECIFIC, INTRAMOLECULAR CROSS-LINKING OF PIN1 ACTIVE SITE 
RESIDUES BY THE LIPID ELECTROPHILE 4-OXO-2-NONENAL 
 
Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-27. 
Copyright 2015 American Chemical Society.1 
 
Introduction 
Polyunsaturated fatty acids in cellular membranes are major targets for oxidative damage 
induced by xenobiotics and inflammatory stimuli. The initial oxidation products are fatty acid 
hydroperoxides, which can be converted to a number of reactive lipid electrophiles. Some of these 
electrophiles are readily diffusible and can modify proteins and DNA, thereby propagating damage 
initiated by oxidation.66,120 This may be an important contributor to diseases associated with 
environmental exposures or chronic inflammation such as Parkinson’s disease, atherosclerosis, 
diabetes, and cancer.121,119 
Lipid peroxidation generates a plethora of electrophilic products, varying in length and 
reactivity; two of considerable interest are 4-hydroxy-2-nonenal (HNE) and 4-oxo-2-nonenal 
(ONE) (Figure 22). HNE and ONE react rapidly with the side chains of Cys, His, and Lys residues 
in proteins via Michael addition. HNE and ONE can also form Schiff bases through reaction with 
Lys residues while ONE alone is capable of 4-ketoamide formation.66,71 ONE is >150-fold more 
reactive than HNE and displays a broader range of reaction products due to differences in its 
stereoelectronic properties.150,78 Comprehensive proteomic analyses indicate that HNE and ONE 
react with many proteins in cells (> 1,000), but they display significant differences in protein 
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targets and sites of reactivity;86,84,5 few studies have investigated the precise mechanisms 
responsible for these differences. 
 
 
We recently reported that HNE reacts with the active site Cys of the peptidyl-prolyl isomerase, 
Pin1, to form a covalent Michael adduct in vitro and in cells exposed to HNE.87 Pin1 is the only 
known isomerase to specifically target proline-directed epitopes preceded by a phosphorylated 
Ser/Thr residue. Pin1 isomerizes this bond from cis to trans, thereby facilitating dephosphorylation 
by isomer-specific phosphatases.151 This unique activity of Pin1 results in the stabilization and/or 
transactivation of an impressive list of substrates, including p53,152 b-catenin,153 Raf,154 Rb,155 and 
tau,151 among many others. Modification of Pin1 by HNE has been detected by immunochemical 
analysis of affected regions of brains from Alzheimer’s disease patients, and the extent of 
modification appears to correlate to disease severity.156,157 
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Figure 22. Structures of lipid electrophiles used in these studies. Reproduced with permission from Aluise et al. (2015) 
Chem. Res. Toxicol. 28(4):817-27. Copyright 2015 American Chemical Society.1 
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Preliminary investigation of the reaction of ONE with Pin1 indicated that, like HNE, it targets 
the catalytic Cys. However, detailed analysis indicated that the product of ONE-mediated Pin1 
modification is not a simple Michael addition product but rather a stable intramolecular cross-link 
that forms rapidly and in high yield. We report here the structure of the adduct, a potential 
mechanism of reactivity, and evidence for the modification of Pin1 by ONE in intact cells. 
Efficient production of this adduct in Pin1, and in other proteins with similar surface exposed, 
active site-localized Cys-Lys residues may contribute significantly to the cellular effects of ONE 
associated with oxidative stress. 
 
Materials and Methods 
Materials and Reagents. All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless 
otherwise stated. ONE, 8,9-alkynyl-ONE (aONE), and UV-cleavable biotin azide were 
synthesized in the laboratory of Dr. Ned Porter at Vanderbilt University as previously described.5 
Cell culture medium was purchased from Invitrogen (Grand Island, NY). Fetal bovine serum 
(FBS) was purchased from Atlas Biologicals (Ft. Collins, CO). Purified Pin1 protein (GWB-
523EFE) was purchased from Genway Biosciences (San Diego, CA). Anti-Pin1 antibodies were 
purchased from Cell Signaling (Danvers, MA), and secondary antibodies were purchased from 
Santa Cruz Biotechnologies (Santa Cruz, CA). All SDS-PAGE and western blot supplies were 
purchased from Bio-Rad (Hercules, CA) unless otherwise noted. Streptavidin Sepharose High 
Performance beads were purchased from GE Life Sciences (Pittsburg, PA). 
 
Cell Culture and Treatments. The triple-negative human breast carcinoma MDA-MB-231 cell line 
was purchased from the American Type Culture Collection (ATCC). Cells were cultured in 
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RPMI1640 Medium (Gibco) with 10% FBS. Electrophiles dissolved in DMSO or vehicle control 
were added to cell culture medium to achieve the desired electrophile concentration while 
maintaining a DMSO concentration of less than 1%.  
 
Synthesis of Deuterated ONE Analogues. Deuterated ONE analogues were synthesized according 
to the method of Blair158 with some modification. 4-hydroxy-non-2-ynal diethylacetal was 
synthesized by the Grignard reaction of hexanal with propiolaldehyde diethylacetal magnesium 
bromide. The reduction of 4-hydroxy-non-2-ynal diethylacetal with lithium aluminum hydride and 
work-up with deuterium oxide saturated with deuterated ammonium chloride gave 2-[2H]-4-
hydroxy-non-2-enal-diethylacetal. Deprotection of 2-[2H]-4-hydroxy-non-2-enal-diethylacetal in 
1% citric acid gave 2-[2H]-4-hydroxy-non-2-enal. Finally, Dess-Martin oxidation of 2-[2H]-4-
hydroxy-non-2-enal provided 2-[2H]-4-oxo-non-2-enal (2D-ONE). For the synthesis of 3-[2H]-4-
oxo-non-2-enal (3D-ONE), 4-hydroxy-non-2-ynal diethylacetal was reduced with lithium 
aluminum deuteride, and the reaction was quenched by the addition of a saturated solution of 
ammonium chloride in water to give 3-[2H]-4-hydroxy-non-2-enal-diethylacetal. Subsequent 
deprotection under acidic conditions followed by Dess-Martin oxidation resulted in the formation 
of 3D-ONE. 
 
Click Chemistry. MDA-MB-231 cells were exposed to aONE for 1 h in serum-free medium. 
Following electrophile exposure, cells were washed with Dulbecco’s-modified phosphate-
buffered saline (DPBS, Gibco), collected by scraping, and centrifuged for 5 min at 1000 x g. Cell 
pellets were lysed in NETN buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 0.5% Igepal, and 
mammalian protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO)). Pellets were sonicated by 
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ten 1s pulses with a Virsonic Cell Disruptor and cleared by centrifugation at 16,000 x g for 10 min. 
The bicinchoninic acid assay was used to determine protein concentration (Thermo Scientific, 
Waltham, MA). Click chemistry and photoelution were performed as previously described.87 
 
SDS-PAGE and Western Blotting. Protein samples for SDS-PAGE were mixed 1:1 by volume with 
2X Laemmli buffer containing 5% β-mercaptoethanol and boiled for 5 min. A 4-20% gradient 
Tris-HCl gel was used to separate proteins. Proteins in the gel were transferred onto a 0.45 µm 
nitrocellulose membrane and blocked with 5% nonfat dry milk in Tris-buffered saline containing 
0.1% Tween-20 (TBST) for 1 h. Primary antibodies were incubated (1:1000 for anti-Pin1) with 
membranes overnight at 4oC. The following day, blots were washed with TBST three times and 
incubated with anti-rabbit secondary antibody (1:5000) for 1 h at room temperature (RT). Blots 
were washed three times with TBST and developed using luminol-based detection (Perkin-Elmer, 
Santa Clara, CA).  
 
In-Solution Modification of Purified Pin1. Purified Pin1 was buffer-exchanged once with DPBS. 
Protein (2.5 µg, 6.9 µM) was diluted to 20 µL with DPBS and incubated with electrophile at 37oC 
as indicated. Reactions were terminated with the addition of NaBH4  at a final concentration of 20 
mM for 30 min at RT. Protein samples were dried in vacuo and reconstituted in 10 µL of 6 M 
guanidine hydrochloride for 30 min at RT. Samples were reduced with dithiothreitol (150 µM) for 
30 min at 37oC, and alkylated by 750 µM iodoacetamide for 15 min at RT in the dark prior to 
being diluted to 200 µL with 20 mM NH4HCO3. Due to the potential of adducts on Lys residues 
to result in mis-cleavage by trypsin, samples were digested with 500 ng chymotrypsin (Promega, 
Madison, WI) for 24 h at 37oC. Chymotryptic digests were concentrated and desalted using 
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ZipTips, (EMD Millipore, Billerica, MA) and eluted from tips with 60% acetonitrile/0.1% 
trifluoroacetic acid. Samples were mixed 1:1 by volume with matrix (20 mg/ml α-cyano-
hydroxycinnamic acid (CHCA) in 60% acetonitrile) and analyzed by MALDI-TOF MS.  
 
Analysis of Pin1 Peptides via MALDI-TOF and MALDI-TOF/TOF MS. An Autoflex Speed TOF 
MS or an Ultraflextreme TOF/TOF MS (Bruker Daltonics), both equipped with a Nd:YAG (solid 
state) laser operating at 355 nm, were used to obtain spectra. All spectra were obtained in positive 
ion mode. Peptide-CHCA solutions (1 µL) were deposited on 384-spot MALDI target plates and 
air dried prior to analysis.  Full mass spectra of peptides were obtained in reflectron mode on the 
Ultraflextreme, using a 500-4500 mass range. Spectra from treated and untreated samples were 
overlaid to identify peaks corresponding to masses appearing in spectra from ONE-treated Pin1 
samples which did not appear in unmodified Pin1 samples. Selected peptide ions were dissociated 
using LIFT on the TOF/TOF. TOF/TOF fragmentation data were interrogated using FlexAnalysis 
software and analyzed against a theoretical Pin1 peptide digest using Protein Prospector. 
 
Analysis of Pin1 Peptides via Orbitrap MS/MS. Purified Pin1 was buffer-exchanged once with 
DPBS. Protein (2 µg, 5.5 µM) was diluted to 20 µL with DPBS and incubated with 25 µM 
electrophile at 37oC with agitation. Reactions were terminated with NaBH4 at a final concentration 
of 20 mM for 30 min at RT. Samples were reduced with 150 µM DTT for 45 min, and available 
Cys residues were carbamidomethylated with 750 µM iodoacetamide for 45 min. Pin1 was 
digested with chymotrypsin (10 ng/µL) in 25 mM NH4HCO3 for three hours at 37°C. The samples 
were dried by vacuum centrifugation, and the peptides were reconstituted in 0.1% formic acid. 
Peptides were loaded onto a capillary reversed-phase analytical column (360 µm o.d. × 100 µm 
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i.d.) using an Eksigent NanoLC Ultra HPLC and autosampler. The analytical column was packed 
with 20 cm of C18 reversed-phase material (Jupiter, 3 µm beads, 300 Å, Phenomenex), directly 
into a laser-pulled emitter tip. Peptides were gradient-eluted at a flow rate of 500 nL/min, and the 
mobile phase solvents consisted of water containing 0.1% formic acid (solvent A) and acetonitrile 
containing 0.1% formic acid (solvent B). A 90 min gradient was performed, consisting of the 
following: 0–10 min, 2% B; 10–50 min, 2–45% B; 50–60 min, 45–90% B; 60–65 min, 95% B; 
65–70 min 95–2% B; and 70–90 min, 2% B. Eluting peptides were mass analyzed on an LTQ 
Orbitrap Velos MS (Thermo Scientific), equipped with a nanoelectrospray ionization source. The 
instrument was operated using a data-dependent method with dynamic exclusion enabled. Full-
scan (m/z 300–2000) spectra were acquired with the Orbitrap (resolution 60,000), and the top 16 
most abundant ions in each MS scan were selected for fragmentation in the LTQ. An isolation 
width of 2 m/z, activation time of 10 ms, and 35% normalized collision energy were used to 
generate MS2 spectra. Dynamic exclusion settings allowed for a repeat count of 2 within a repeat 
duration of 10 s, and the exclusion duration time was set to 15 s. For identification of Pin1 peptides, 
tandem mass spectra were searched with Sequest (Thermo Scientific) against a human subset 
database created from the UniprotKB protein database (www.uniprot.org). Variable modifications 
of +57.0214 on Cys (carbamidomethylation), +15.9949 on Met (oxidation), +141.1279 on Lys and 
Arg (corresponding to reduced Schiff base), +158.1306 on Cys, Lys, and His residues 
(corresponding to reduced ONE modification), +156.1150 on Lys (corresponding to the 4-
ketoamide), and +118.0783 on Cys or Lys (corresponding to the pyrrole cross-link) were included 
for database searching. Search results were assembled using Scaffold 3.0 (Proteome Software). 
Spectra acquired of Pin1 peptides of interest were then inspected using Xcalibur 2.1 Qual Browser 
software (Thermo Scientific). The 4-ONE-cross-linked Pin1 peptide SDCSSAKARGDLGAF was 
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confirmed following manual examination of the corresponding MS1 and MS2 spectra. For analysis 
of sample sets including 2D and 3D 4-ONE treatments, Pin-1 was similarly digested with 
chymotrypsin and peptides were subsequently analyzed using a targeted LC-MS/MS method on 
the LTQ Orbitrap Velos. A 90 min gradient was performed, consisting of the following: 0–14 min, 
2-5% B; 14–70 min, 5–40% B; 70–78 min, 40–92% B; 78-79 min, 92-2% B; 79–90 min, 2% B. 
For analysis of deuterium-containing cross-linked peptides, the LTQ Orbitrap Velos was operated 
using a combination method of data-dependent and targeted scan events. Targets were of specific 
m/z values corresponding to 4-ONE cross-linked peptide, SDCSSAKARGDLGAF, and m/z 
values included those that would correspond to non-deuterated as well as deuterated cross-link 
forms. For these targeted scan events, MS2 spectra were acquired using the Orbitrap as the mass 
analyzer such that data were collected at higher resolution.  Specifically, mass resolution of 15,000 
was employed and target AGC values were increased to 2e5 with a max ion time of 250ms. All 
high-resolution MS2 data were analyzed by manual interrogation of unprocessed spectra. 
 
Results 
Pin1 modification by ONE results in a Cys-Lys pyrrole-containing cross-link in the active site  
To investigate the adduct chemistry of ONE-adducted Pin1, adducted peptides were examined for 
ions that were not present in an unmodified Pin1 digest; three new adduct ions were detected in 
the ONE-treated Pin1 sample. Our previous study identified the ion appearing at 1542 m/z to be 
the Cys113-containing peptide.87 Although this peak was again present in the control Pin1 digest 
(Figure 23A), it was completely absent in the ONE-treated sample and was replaced by a peak at 
1603 m/z (Figure 23B). The TOF/TOF spectrum of m/z 1603 (Figure 24B)was identified as the 
peptide containing Cys113, as evidenced by the most intense ions matching the theoretical peptide 
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spectrum, but with a mass shift of +61 m/z relative to the carbamidomethylated peptide (Figure 
24A). This mass shift represents a total mass shift of +118 m/z relative to the unmodified, non-
carbamidomethylated peptide. A previous study on the reaction of ONE with Histone H4 reported 
a +118 m/z mass shift corresponding to a His-Lys pyrrole-containing interpeptide cross-link.79 
Therefore, we interrogated the possibility of an active site cross-link resulting from ONE reaction 
with Pin1.  
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Figure 23. MALDI-TOF spectra of chymotryptic peptides generated from Pin1. Pin1 was treated with A) vehicle 
(DMSO) or B) 300 µM ONE, digested with chymotrypsin, and subjected to MALDI-TOF. Treatment with ONE results 
in complete or nearly complete disappearance of the 1078, 1542, and 1685 m/z peaks and the appearance of 1234, 
1603, and 1841 m/z peaks. Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-27. 
Copyright 2015 American Chemical Society.1 
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All of the most intense ions in the TOF/TOF fragmentation spectrum of 1603 m/z were 
identified as fragment masses of SDCCamSSAKARGDLGAF N-terminal to Ala-118 with a 
variable mass shift of +61 m/z placed on either the Cys or Lys (Figure 24B). Reduction of ONE-
modified Pin1 with NaBH4, did not result in a mass shift, as evidenced by MALDI-TOF MS, 
suggesting the absence of a reducible carbonyl group (Figure 25B). By contrast, treatment of HNE-
modified Pin1 with NaBH4 resulted in a shift of +2 Da resulting from the reduction of the aldehyde 
group in the Cys113 Michael adduct to the corresponding alcohol (Figure 25A). The isotopic 
distribution of 1603 m/z in the ONE-Pin1 spectrum indicates a +1 charge state (data not shown), 
minimizing the possibility of a multiply charged interpeptide cross-link.  
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Figure 24. TOF/TOF spectra of the chymotryptic peptide containing the Pin1 active site. Pin1 active site Cys 
(SDCSSAKARGDLGAF) following A) carbamidomethylation (Cam) with a parent ion at 1542 m/z and B) ONE-
treatment, resulting in a cross-link between Cys and Lys with a parent ion at 1603 m/z. In the cross-linked peptide 
fragmentation, the ions C-terminal to the Lys match the indicated peptide when an additional mass of +61 m/z relative 
to the carbamidomethylated peptide (57 Da + 61 Da = 118 Da) is considered on either the Cys or the Lys. Reproduced 
with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-27. Copyright 2015 American Chemical 
Society.1 
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To determine the requirement of Cys113 for cross-link formation, Pin1 was pretreated with  
iodoacetamide to block Cys residues prior to ONE treatment. Under these conditions, the 1603 m/z 
peptide was eliminated; however, treatment with iodoacetamide after Pin1 modification by ONE 
did not interfere with the formation of the 1603 m/z peptide (Figure 26A). Similarly, to assess the 
requirement of Lys117, Pin1 was preteated with acetic anhydride, resulting in Lys acetylation, to 
block accessible Lys residues prior to ONE treatment. These conditions prevented the appearance 
A
B
Figure 25. Analysis of the effects of NaBH4 reduction on the Cys113-containing peptide. Pin1was treated with HNE 
or ONE, reduced with NaBH4, and digested with chymotrypsin. Cys113-HNE and suspected Cys113-Lys117 pyrrole 
ONE adduct. A) Pin1 exposed to HNE and treated with (solid line) or without (dashed line) NaBH4. B) Pin1 exposed 
to ONE with (solid line) or without (dashed line) NaBH4. Reproduced with permission from Aluise et al. (2015) Chem. 
Res. Toxicol. 28(4):817-27. Copyright 2015 American Chemical Society.1 
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of the 1603 m/z ion whereas acetic anhydride treatment after ONE modification did not (Figure 
26B). These data are supportive of an intrapeptide pyrrole-containing cross-link of +118 m/z 
resulting from the reaction of ONE with Cys113 and Lys117.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 68 
 
 
 
A
B
Figure 26. Effect of iodoacetamide and acetic anhydride on ONE-dependent Pin-1 adduction. A) Pin1 was treated 
with 750 µM iodoacetamide (IA) prior to (dashed line) or after (solid line) exposure to ONE. B) Pin1 was treated with 
5mM acetic anhydride (AA) prior to (dashed line) or after (solid line) exposure to ONE.  Pretreatment of Pin1 with 
either IA or AA prior to ONE prevents formation of the ONE adduct (1603 m/z), while treatment of Pin1 with either 
reagent after ONE exposure had no effect on adduct formation, suggesting a requirement for both Cys and Lys in 
adduct formation. Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-27. Copyright 
2015 American Chemical Society.1 
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The Cys-Lys pyrrole cross-link in the active site of Pin1 forms more rapidly than other observed 
ONE-modifications 
Two additional peaks with m/z values corresponding to Pin1 peptides containing ONE-
modifications were also identified (Figure 24B), although both were present in low abundance 
relative to the ion of the Cys113-Lys117 cross-link. Peptide masses of 1234 m/z and 1842 m/z in 
the spectrum of ONE-treated Pin1 corresponded to addition of +156 m/z to SRGQMQKPFEDSAF 
and ADEEKLPPGWEKRM, respectively. This mass shift is suggestive of reduced 4-ketoamide 
adducts derived from ONE modification of Lys residues.71,72 Due to the relatively low ion 
intensities of these adducts formed upon Pin1 reaction with ONE, MALDI-TOF/TOF 
fragmentation resulted in rather low quality spectra; therefore to further verify the sites of these 
adducts using a more sensitive approach, we analyzed these peptides using LC-coupled tandem 
mass spectrometry (LC-MS/MS). LC-MS/MS analysis of Pin1 treated with ONE identified 3 total 
adducts: the suspected cross-link, and one each on Lys residues contained in the suspected peptides 
from the MALDI experiment (SRGQMQKPFEDSAF and ADEEKLPPGWEKRM). The 
fragmentation of 1234 m/z indicates a ketoamide at Lys132 (Figure 27A), which was previously 
identified as a site for Michael addition on Pin1 by HNE.87 Because ADEEKLPPGWEKRM 
contains two Lys residues (Lys6 and Lys13), fragmentation of the ion was necessary to identify 
the specific amino acid site of modification. LC-MS/MS fragmentation spectra of peptides from 
Pin1 treated with ONE identified Lys13, not Lys6, as the site of adduction on this peptide (Figure 
27B).  
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Figure 27. Tandem mass spectra of peptides with the 4-ketoamide adduct. Tandem mass spectra of A) m/z 1234 
corresponding to SRGQMQKPFEDSAF and B) m/z 1842 corresponding to ADEEKLPPGWEKRM. Both spectra 
show a mass shift of +154 m/z, indicative of a 4-ketoamide adduct on Lys. Reproduced with permission from Aluise 
et al. (2015) Chem. Res. Toxicol. 28(4):817-27. Copyright 2015 American Chemical Society.1 
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Since more than one adduct was identified in ONE-treated Pin1, we examined their relative 
rates of formation using MALDI-TOF MS. After proteolysis, peaks corresponding to unmodified 
and modified Pin1 peptides are detectable simultaneously in the MALDI-TOF spectra, so the 
relative rates of modification of the individual sites can be deduced.159 Pin1 was incubated with 
either a fixed concentration of ONE for varying times or with varying concentrations of ONE for 
a fixed time. As shown in Figure 28A, the Cys-Lys pyrrole cross-link is formed very rapidly and 
at the lowest concentration of ONE. In contrast, the formation of ketoamide adducts at Lys132 or 
Lys13 requires high ONE concentrations (Figure 28B) and long reaction times. Comparison of the 
modification of Cys113 by equivalent concentrations of ONE and HNE indicated high reactivity 
with ONE but no reaction with HNE (Figure 29). 
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Figure 28. Relative reactivity of recovered Pin1 adducted peptides. Reactivity of Pin1 adducted peptides as a function 
of A) time of exposure to 200µM ONE and B) ONE concentration for 1 h. % Modified was calculated using the ion 
intensity of the formed adduct divided by the sum of the intensities of the adduct ion and the corresponding unadducted 
ion. The Cys113-Lys117 pyrrole adduct (solid line) outcompetes the other two adducts (Lys13 (dashed line), Lys132 
(dotted line)) observed. Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-27. 
Copyright 2015 American Chemical Society.1 
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Reaction of Pin1 with Specifically Deuterated ONE 
To determine the mechanism of cross-link formation and further elucidate the possible structure, 
deuterated ONE analogs were synthesized to contain a deuterium at C2 or at C3, designated 2D-
ONE and 3D-ONE (Figure 22), respectively. Recombinant Pin1 was incubated with vehicle 
control, ONE, 2D-ONE, or 3D-ONE (25 µM) for 1 h, carbamidomethylated, and then digested 
with chymotrypsin. Under these conditions, the Cys113-containing peptide 
(SDCCamSSAKARGDLGAF), is observed as parent ion with a +2 charge at 771.35 m/z (Figure 
30A). Treatment with ONE results in a mass shift of +61 (m/z 30.5), producing a parent ion at 
801.88 m/z consistent with formation of the cross-link (Figure 30B). The 2D-ONE-treated sample 
has a major +2 parent ion at 802.38 m/z. This observed ion has a mass error of 1.2 ppm relative to 
the theoretical mass of the peptide containing a deuterium within the cross-link, thereby verifying 
the presence of deuterium at the C2 position in the cross-link. Additionally, fragmentation of 
Figure 29. Competition of HNE versus ONE for the active site Cys (Cys113). Pin1 was incubated with DMSO (dashed 
line) or a 50:50 mixture of 150µM each HNE:ONE (solid line), digested with chymotrypsin, and analyzed by MADLI-
TOF mass spectrometry for the presence of the Cys113-HNE Michael adduct (1643 m/z) and the Cys113-Lys117 
ONE cross-link (1603 m/z). Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-
27. Copyright 2015 American Chemical Society.1 
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802.38 m/z showed a shift in the observed b-series ions corresponding to the presence of deuterium 
in fragment ions containing the cross-linked portion of the peptide (Figure 30C). Interestingly, the 
801.88 m/z peak is still present in the isotopic distribution of SDCSSAKARGDLGAF with the 
2D-ONE, indicative that some cross-linked peptides do not contain the deuterium. The spectrum 
for the 3D-ONE sample shows the dominant +2 parent ion at 801.88 m/z, 0.4 ppm relative to the 
theoretical mass of the non-deuterated cross-link. Fragmentation of this peptide shows a spectrum 
identical to that of the undeuterated ONE sample, further indicating that the deuterium is not 
present in the cross-link (Figure 30D). These data indicate that the first step in cross-link formation, 
Michael addition of Cys113, occurs through nucleophilic attack at C3 of ONE, resulting in the loss 
of the deuterium in that position (Figure 31). 
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Figure 30. Tandem mass spectra of SDCSSAKARGDLGAF with deuterated ONE analogues. Tandem mass spectra 
of SDCSSAKARGDLGAF at A) m/z 771.35 for DMSO-treated, B) m/z 801.88 for ONE-treated, C) m/z 802.39 for 
2D-ONE-treated, and D) m/z 801.88 for 3D-ONE-treated Pin1. Reproduced with permission from Aluise et al. (2015) 
Chem. Res. Toxicol. 28(4):817-27. Copyright 2015 American Chemical Society.1 
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Figure 31. Proposed mechanism of cross-link formation. Cross-link formation is initiated by nucleophilic attack of 
the thiolate of Cys to C3 of ONE. The ε-amine of Lys then attacks C1 of ONE to form the carbinolamine, followed 
by an additional attack to C4 of ONE to form the pyrrolidine. Two dehydration reactions result in the formation of the 
pyrrole-containing cross-link. Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-
27. Copyright 2015 American Chemical Society.1  
 77 
Pin1 is a target of ONE in MDA-MB-231 cells 
To assess the susceptibility of Pin1 to modification by ONE in a cellular setting, MDA-MB-231 
cells were treated with varying concentrations of aONE (Figure 22)for 1 h. Following click 
chemistry, streptavidin pull-down, and cleavage of the photocleavable biotin linker, Pin1 western 
blotting was conducted. As shown in Figure 32, Pin1 is susceptible to modification by aONE at 
10 µM, which is within the pathological range of electrophiles.66,160,161 Given the high efficiency 
of formation of the Cys-Lys cross-link in vitro, it is likely that this is the identity of the 
modification in the intact cells.  
 
 
Discussion   
Many previous studies on the reactivity of lipid electrophiles with proteins have focused 
on HNE, as it has long been considered a major lipid hydroperoxide-derived electrophile. 
However, the discovery of ONE as another important electrophilic product of lipid peroxidation 
has generated interest in the relative reactivity of ONE with DNA and proteins, as compared to 
that of HNE. Relative to ONE, HNE-protein adducts are relatively straightforward to investigate, 
mainly because the principal reaction of HNE with proteins is the formation of Michael adducts to 
Figure 32. Western blot of adducted Pin1 from aONE-exposed MDA-MB-231 cells. Click chemistry was performed 
on total cells lysates with increasing concentrations on aONE. Following photo-elution of aONE-modified proteins, 
eluates (adducted) and total cell lysates (input) were separated by SDS-PAGE and subjected to western blot with anti-
Pin1 antibody. Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 28(4):817-27. Copyright 
2015 American Chemical Society.1 
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Cys or His residues. In contrast, despite a difference in structure of only two hydrogen atoms, 
ONE-derived modifications to proteins can be profoundly more difficult to characterize, largely 
due to the rapid reactivity with Cys and Lys residues, the potential to cross-link between two 
residues, and the ability to generate adducts with multiple chemical structures depending on the 
microenvironment.162,64,71,72 Therefore, the physiological spectrum of potential adducts arising 
from ONE is far more complicated than that of HNE.64 Additionally, some ONE adducts, including 
the ketoamide and possibly the cross-link, are irreversible, making these adducts significantly 
more stable and inherently longer lived.72 The more persistent effects of ONE modifications makes 
them a pivotal area of research. 
Due to the fact that ONE generates various structural modifications, MS-based analysis of 
ONE-treated proteins likely provides the most information in elucidating site-specific protein 
adducts. Incubation of purified Pin1 with ONE revealed mass shifts of +156 m/z and +118 m/z 
relative to Pin1 chymotryptic peptides. Through multiple independent experiments, our data 
support the identity of an ONE adduct to Pin1 as a Cys-Lys pyrrole-containing cross-link in the 
active site of the protein (Figure 31). Blockage of either Cys113 or Lys117 by iodoacetamide and 
acetic anhydride, respectively, prevented the formation of the cross-link by ONE. Furthermore, 
reduction via NaBH4 did not result in an additional mass shift. These data suggest that the resulting 
adduct does not contain a carbonyl functionality, further indicating the pyrrole adduct, which lacks 
a carbonyl. This adduct was formed at lower concentrations of ONE and shorter incubation times, 
than other ONE adducts, and its formation also completely outcompeted the formation of the Cys-
HNE Michael adduct, indicating that this reaction proceeds with considerable efficiency relative 
to those of many other electrophile-protein modifications.   
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A Cys-Lys pyrrole-containing cross-link derived from ONE was detected by Zhu et al.163 
in the reaction of oxidized linoleic acid with b-lactoglobulin, but it represented a small fraction of 
the total ONE adduct burden; this contrasts with the present findings with Pin1, which indicate 
that the pyrrole-containing cross-link forms rapidly and in high yield. Examination of the crystal 
structure of Pin1 provides insights into the possible reasons for the high reactivity of Pin1 with 
regard to formation of this adduct (Figure 33). Cys113 sits in the active site of the enzyme and is 
separated from Lys117 by only 6.5 Å. Lys117 is located on the turn of a short alpha helix (5 amino 
acids) C-terminal to Cys113. The Lys117 side chain is directed toward Cys113, facilitating 
reaction of the amino group with the initial Michael adduct formed by reaction of ONE with the 
catalytic Cys (Figure 31). Since Cys113 participates as a nucleophile in peptidyl cis-trans 
isomerization, it has enhanced nucleophilicity compared to those of other nucleophilic sites in the 
protein, allowing it to trap ONE and position the carbonyl groups of the Michael adduct adjacent 
A B
Figure 33. Pin1 crystal structure. A) Crystal structure of Pin1 highlighting Lys117 and Cys113 (black). B) Cys113 
side chain orientation relative to Lys117. Reproduced with permission from Aluise et al. (2015) Chem. Res. Toxicol. 
28(4):817-27. Copyright 2015 American Chemical Society.1 
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to Lys117 for condensation. Oe et al.79 have reported the formation of a His-Lys pyrrole-containing 
cross-link on reaction of ONE with Histone H4 between His75 and Lys77, and indicated that –
HAK– amino acid sequences in proteins may represent a primary sequence target motif for 
formation of the pyrrole adduct resulting from ONE. This adduct could also likely be formed 
between a Cys/His residue distant from a Lys residue based on primary sequence, but spatially 
close based on the three dimensional structure of the protein. The Cys-Lys epitope modified by 
ONE in Pin1 is both spatially close and separated by only four amino acids, supporting the 
feasibility of the reaction for this specific protein. The studies with deuterated ONE analogs further 
support the mechanism of pyrrole cross-link formation predicted by Oe et al.79 (Figure 31). 
Treatment of cells with aONE followed by click chemistry conjugation to biotin revealed 
that Pin1 is modified by aONE as a function of concentration. The results support that aONE does 
not alter the total level of Pin1, but rather modifies the existing pool of protein. Interestingly, 
oxidative modification of Pin1 has been observed in the brains of Alzheimer’s disease patients, 
and the modification leads to inhibition of Pin1 isomerase activity.164 Pin1 inhibition has been 
suggested to underlie the formation of neurofibrillary tangles in AD brain, thereby catalyzing 
disease pathogenesis.165 Isomer-specific antibodies of tau, a Pin1 substrate, display increased cis-
tau labeling in AD brain compared to control brain, indicating a Pin1 inhibitory event.166 Due to 
the rapid formation of the Cys-Lys pyrrole adduct in our in vitro experiments, we expect the same 
modification to occur in cells exposed to ONE. Furthermore, Miyashita et al.167 demonstrated that 
adduction of a pyrrole onto Lys residues increases protein surface electronegativity, resulting in 
the formation of a damage-associated molecular pattern capable of triggering an autoimmune 
response.     
Cis isomers of proline-containing peptide bonds occur with a frequency of 5-6%, and many 
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of these bonds are present at bend, coil, or turn conformations, which are surface exposed.168,169 
Phosphorylation of serine or threonine preceding a proline in peptide bonds renders this motif 
resistant to isomerization by conventional PPIases, except Pin1. Pin1 binds protein substrates 
through a conserved WW-binding domain, followed by isomerization of the peptide bond by the 
PPIase domain. Some protein substrates of Pin1 contain multiple pSer-Pro or pThr-Pro motifs, and 
the overall 3-dimensional structure and, therefore, protein activity, can be dictated by whether 
these bonds are in cis or trans.170 Because modifications to Pin1 can adversely affect the network 
of proteins it controls, elucidation of potential oxidative adducts to this protein is of high 
importance, particularly considering that oxidative stress and Pin1 dysfunction coexist in some 
diseases.171 The ONE adduct to Pin1 may be a particularly important contributor to cellular 
dysfunction associated with oxidative stress because it forms rapidly and in high yield, completely 
blocks the active site, and is irreversible. The biological implications of Pin1 cross-linking by ONE 
are currently being explored by our laboratory. 
 
Additional Investigation into ONE Cross-links 
 Since ONE was able to form an intrapeptide cross-link on Pin1, we wished to investigate 
if other proteins were susceptible to ONE cross-linking. To address this question, we employed a 
computational approach in collaboration with Dr. Jarrod Smith in the Center for Structural 
Biology. We searched the Protein Data Bank (PDB) for crystal structures of 162 proteins that were 
shown to be highly reactive toward aONE based on the work of Codreanu et al.,84 This search 
found 389 structures for 153 of the proteins.  We then analyzed all these crystal structures for a 
Cys residue within 10 Å of a Lys residue, as the key structural criterion for ONE-dependent cross-
link formation. The search revealed 30 unique proteins that fulfilled these criteria (Table 3).  
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Among the proteins identified was thioredoxin (TRX), which had previously been shown 
to be a target of HNE modification at the redox-sensitive Cys.172 Using recombinant TRX1, we 
incubated the protein in vitro with ONE, digested with trypsin, and performed tandem mass 
spectrometry to assess sites of modification. While multiple Lys residues were adducted by ONE 
in the form of both Michael adducts and the 4-ketoamide, no modifications were observed on Cys. 
Additional attempts to reduce disulfides on recombinant TRX1 prior to ONE treatment did not 
yield observable cross-links at the active site.  
 The lack of ONE adducts on Cys was unexpected, especially due to the evidence that the 
redox-senstive Cys residues are adducted by HNE and because TRX1 is adducted by aONE based 
on the proteomic inventory published by Codreanu et al.84 We hypothesize that the lack of Cys 
modifications was due to the incomplete reduction of disulfides or preferential reformation of 
disulfides prior to ONE exposure. Structurally, the two redox-active Cys residues are in close 
proximity, and mechanistically, disulfide bond formation is required as part of the redox cycle of 
TRX1. Therefore, in our in vitro setting, it is conceivable that disulfide bonds may reform 
immediately upon removal of reductant. In a cellular setting, ONE modification of the active-site 
Cys residues may occur, along with cross-link formation, but it is unlikely that we will be able to 
Possible Proteins	Cross-linked	by	ONE
TXN YWHAE RUVBL2 CDC37 PABCP1 EIF4A1
PKM2 HSPA8 HSP90AB1 YWHAZ CLTC HSP86
HSPA9 HSPA2 SHMT2 TFRC GARS HNRNPM
PGK1 MYH9 HARS PFN1 LDHA HSPA1A
YWHAQ ANXA2 MDH2 NME1 UBB STIP1
Table 3. Possible proteins cross-linked by ONE. 
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observed the cross-link in cellular TRX1 due to inefficient protein purification. One additional 
residue, Cys72, is also in close proximity to a Lys and has the potential to form a cross-link. This 
Cys is not redox active, and no ONE adducts were found at this site. 
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CHAPTER IV 
 
CLICK-SEQ: CLICK CHEMISTRY AND NEXT-GENERATION SEQUENCING FOR 
THE STUDY OF 4-OXO-2-NONENAL HISTONE MODIFICATIONS 
 
Introduction 
Oxidative stress plays a key role in a number of diseases, including cancer, atherosclerosis, 
neurodegenerative disease, and asthma.121 Reactive oxygen species generated during periods of 
high oxidative stress readily react with cellular proteins, DNA, and polyunsaturated fatty acids in 
the membranes. Decomposition of these oxidized lipids results in the formation of reactive lipid 
aldehydes, such as 4-hydroxy-2-nonenal (HNE) and 4-oxo-2-nonenal (ONE), which can react with 
nucleophilic centers in the cell, particularly Cys, His, and Lys residues on proteins, to form 
covalent Michael modifications.66,64 Additionally, ONE displays high reactivity with Lys residues, 
resulting in the formation of Schiff base adducts and the stable 4-ketoamide adduct.71,72 These 
covalent adducts are capable of altering protein function and disrupting key cellular processes. 
Recent advancements utilizing click chemistry have allowed for proteome-wide 
identification of electrophile targets. Alkyne analogues of HNE and ONE, aHNE and aONE, 
respectively, display similar reactivity to their native counterparts, but allow for selective isolation 
by click chemistry conjugation to a photo-cleavable azido-biotin and subsequent streptavidin 
capture and photo-elution.84 While a large number of proteins were found to be targets of the aHNE 
and aONE, histones were highly enriched in the aONE-treated samples. Further reports by 
Galligan et al.88 showed that Lys residues of histones were modified with the stable 4-ketoamide 
adduct (4-Kam-Lys) and that modification of nucleosomes by ONE disrupted nucleosome-DNA 
complexes. H3K27 was determined to contain this adduct in RAW264.7 macrophage cells under 
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inflammatory conditions, suggesting that these modifications occur under pathophysiological 
conditions.  
Epigenetic studies mainly focus on Lys modifications, the most abundant post-
translationally modified residue in histones. Acetylated Lys (AcLys) is a known transcriptional 
activator, likely due to charge neutralization and relaxation of DNA around histones.173 Conversely 
trimethyl Lys (me3Lys) contributes to a net positive change on Lys, resulting in chromatin 
compaction and gene silencing. These post-translational modifications (PTMs) occur at distinct 
residues on the various core histones, and different combinations of these PTMs control chromatin 
structure, DNA accessibility, and the binding of proteins associated with transcriptional regulation.  
Canonical PTMs are tightly regulated by writer, reader and eraser proteins which add the 
modifications, detect them, and remove them. Adduction of Lys by ONE blocks these sites from 
subsequent addition of regulatory PTMs. It is currently unknown if reader proteins can bind to 4-
Kam-Lys. Very recently, SIRT2 was discovered to be an eraser of the 4-ketoamide adduct, though 
removal of the adduct occurs at much lower rates than removal of an acetyl group at the same 
site.174 The stability of the 4-Kam-Lys and its inefficient removal, paired with the disruption of 
canonical regulatory histone PTMs, makes this adduct of great interest in the study of chromatin 
structure and accessibility. 
Here, we employ the RKO cell line to develop a method for isolating DNA associated with 
adducted chromatin proteins using click chemistry. Successful development of this method 
allowed us to apply this technique with DNA sequencing using the K562 cell line, which has been 
used extensively in the ENCODE project, to determine the regions of DNA which are enriched 
with these modifications. Furthermore, we perform absolute quantitation of 4-Kam-Lys in cells to 
show its abundance compared to canonical PTMs. We show that ONE relaxes chromatin and 
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increases accessibility, similar to acetylation, and that these histone adducts are long-lived, 
persisting up to 24 h following initial treatment. Together, our data show that these ONE-derived 
histone modifications may have a significant and sustainable impact on chromatin structure and 
gene regulation. 
 
Materials and Methods 
Materials and Reagents. All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless 
otherwise stated. 4-Hydroxy-2-nonenal (HNE), 4-oxo-2-nonenal (ONE), alkynyl-HNE (aHNE), 
and alkynyl-ONE (aONE) were synthesized in the laboratory of Dr. Ned Porter at Vanderbilt 
University. Cell culture media was purchased from Invitrogen (Grand Island, NY). Fetal bovine 
serum was purchased from Atlas Biologicals (Ft. Collins, CO). Anti-H3 (1:10,000) was purchased 
from Abcam (Cambridge, MA) and IR-streptavidin was purchased from Li-Cor Biosceinces 
(Superior, NE). All SDS-PAGE and western blot supplies were purchased from Bio-Rad 
(Hercules, CA) unless otherwise noted. SimpleBlue SafeStain was purchased from Invitrogen 
(Grand Island, NY). Streptavidin Sepharose High Performance beads were purchased from GE 
Life Sciences (Pittsburg, PA). Dithiothreitol was purchased from Research Products International 
(Mt. Proscpect, IL).  
 
Cell Culture and Treatments. The human myelogenous leukemia cell line, K562, was cultured in 
RPMI with 10% fetal bovine serum. The human colorectal cancer cell line, RKO, were culured in 
DMEM with glutamax with 10% FBS. Cells were incubated at 37°C with 5% CO2. All cell 
treatments were performed with DMSO at a concentration < 0.1%.  
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Chromatin Extraction. Cells were collected by centrifugation at 1000rpm for 5 minutes, washed 
PBS, and stored at -80°C until lysis. Cells were lysed with hypotonic lysis buffer (10mM 
HEPES/KOH, pH 7.9, 1.5mM MgCl2, 10mM KCl, 5mM sodium butyrate, and 0.5% Igepal), with 
protease and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO) on ice for 30 minutes and 
centrifuged at 4,000rpm for 15 minutes. Pelleted nuclei were washed once with hypotonic lysis 
buffer and chromatin was extracted overnight with end-over-end mixing in high salt buffer (20mM 
HEPES, pH 7.9, 25% glycerol, 420mM KCl, 1.5mM MgCl2, 0.2mM EDTA, 5mM sodium 
butyrate). Precipitated chromatin was centrifuged at 4,000rpm for 10 min, washed with minimal 
salt buffer (20mM HEPES, pH 7.9, 1.5mM MgCl2, 0.2mM EDTA, 5mM sodium butyrate) with 
protease and phosphatase inhibitors, and resuspended in minimal salt buffer. BCA assay was used 
to determine protein concentrations according to manufacturer’s protocol (Thermo Fischer 
Scientific, Waltham, MA). 
 
SDS-PAGE and Western Blots. Samples were denatured in 2X Laemmli buffer and heated at 95°C 
for 5 minutes. Proteins were resolved by SDS-PAGE and transferred onto nitrocellulose 
membranes. Membranes were blocked in Odyssey Blocking Buffer (Li-Cor Biosciences) for 1 h 
at room temperature and primary antibodies were applied overnight at 4°C in 1:1 Odyssey 
Blocking Buffer: TBST. Membranes were washed three times in TBST and infrared secondary 
antibodies (Li-Cor) were added at a 1:5000 dilution for 1 h at room temperature. Following three 
additional washes, blots were developed using the Odyssey Infrared Imaging System (Li-Cor). 
 
Click-Seq. Chromatin (1 mg) was sonicated for 12 rounds of 30 1 s pulses at 35% duty cycle on a 
Virsonic Cell Disruptor to achieve DNA fragments averaging 200-
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streptavidin sepharose beads for 2 h at 4°C to remove endogenously biotinylated proteins. Click 
chemistry was performed with 1 mM TCEP, 1 mM CuSO4, 0.1 mM TBTA, and 0.1 mM N3-biotin, 
final concentration, for 2 h at room temperature then dialyzed overnight against PBS to remove 
excess N3-biotin. SDS was added to a final concentration of 0.1% and chromatin was incubated 
overnight with end-over-end mixing with streptavidin sepharose beads at 4 °C. Beads were washed 
three times with ChIP wash buffer I (20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton 
X-100, 0.1% SDS and 0.1% DOC) and ChIP wash buffer II (20 mM Tris, pH 8.0, 500 mM NaCl, 
2 mM EDTA, 1% Triton X-100, 0.1% SDS and 0.1% DOC). DNA and unmodified proteins were 
eluted in 20 mM NaHCO3 with 1% SDS at 65°C for 2 h with intermittent vortexing. Eluated 
supernatant was collected by centrifugation at 16,000 x g for 5 min and split in half for protein and 
DNA analysis. For DNA, remaining protein was digested with 20 µg proteinase K for 2 h at 55°C. 
DNA was purified by phenol/chloroform extraction and ethanol precipitation with 20 µg glycogen. 
DNA was submitted to HudsonAlpha (Huntsville, AL) for ChIP library generation and sequencing. 
Libraries were sequenced on the Illumina HiSeq 2500 with paired-end 50 bp reads at a sequencing 
depth of 25M reads/sample. 
 
DNA Sequencing Analysis. Fastq files were downloaded from HudsonAlpha and concatenated 
according to form single files. Paired-end reads were aligned to the hg19 build using Bowtie2 and 
converted to BAM files, sorted, and indexed using Samtools1.2. Sorted BAM files were used as 
input for MACS2 using the broad option with default settings, which calls peaks by the tag 
distribution along the genome modeled by a Poisson distribution. Called peaks were investigated 
with Integrated Genome Viewer. 
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Partial MNase Digest. ONE was added for 3 h in serum-free medium and chromatin was extracted 
according to above. Following collection of precipitated chromatin, 500 µl of IP Dilution Buffer 
with 3 mM CaCl2 was added. Micrococcal nuclease (MNase; 150 U) was added and samples were 
incubated at 37 °C for the indicated time. Reactions were quenched with the addition of 10 mM 
EDTA and 20 mM EGTA. DNA was extracted using phenol/chloroform extraction and 
precipitated with isopropanol. DNA was resolved on a 1.5% agarose gel. 
 
Proteolytic Digest for Amino Acid Analysis. Chromatin (50 µg) was precipitated with ice-cold 
methanol for 20 min at -20 °C, collect by centrifugation at 14,000 x g, and resuspended in 153 µl 
50 mM NH4HCO3. Digests were performed according to Galligan et al.175 Briefly, isotopically-
labelled internal standards (10 µl) were spiked into the protein sample. Sequencing-grade trypsin 
(Promega) was added (1:50 w/w in 10 µl) and incubated overnight at 37 °C with mixing. Trypsin 
was inactivated by heating at 95 °C for 10 min. Aminopeptidase (25 ul, 2U) was added and 
incubated overnight at 37 °C with mixing, followed by inactivation by heating at 95 °C for 10 min. 
Heptafluorobutyric acid (HFBA; 2 µl) was added as an ion paring agent at a final concentration of 
50 mM. Undigested proteins were removed by centrifugation at 14,000 x g for 10 min and the 
supernatant was analyzed by LC-MS/MS. 
 
Quantitation of Histone PTMs. Amino acid digests were injected onto a Shimadzu Nexera UPLC 
system and separated on a reverse-phase Phenomenex Luna C8 column (2.1 X 50 mm, 3.5 µm) 
(Phenomenex, Torrance, CA) with H2O with 50 mM HFBA (buffer A) and ACN with 50 mM 
HFBA (buffer B) at a flow rate of 0.325 ml/min. The following gradient was used: 0.5 min (2.5% 
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B) à 5.5 min (50% B) à 6 min (80% B) à 9 min (80% B) à 9.5 min (50% B). The following 
transitions were monitored on a SCIEX 6500 QTrap mass spectrometer: 
 
 
Q1 (m/z) Q3 (m/z) Analyte 
147.1 84.1 Lys 
155.1 90.1 13C615N2 Lys 
175.1 70.1 Arg 
185.1 75.1 13C615N4 Arg 
189.2 84.1 acLys/me3Lys 
197.2 91.1 acLys-d8 
197.2 90.1 13C615N2 me3Lys 
132.1 86.1 Leu 
139.1 93.1 13C615N Leu 
161.1 84.1 meLys 
175.1 84.1 me2Lys 
203.1 70.1 S/ADMA 
210.1 77.1 ADMA-d7 
301.2 84.1 4-Kam-Lys 
309.1 90.1 4-Kam-13C615N2 Lys 
 
Table 4. Analytes and the corresponding transitions monitored by LC-MS/MS. 
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Results 
Development of the Click-Seq method for the isolation of DNA associated with adducted 
chromatin-binding proteins 
To assess if these adducts were associated with distinct regions in the genome, we developed a 
method derived from traditional chromatin immunoprecipitation (ChIP) protocols that utilized 
click chemistry and streptavidin capture in place of antibodies. This method, named chromatin 
click and sequencing (Click-Seq) to isolate and sequence the regions of DNA with which these 
adducts associate. The general scheme is depicted in Figure 34. 
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Figure 34. General scheme for Click-Seq. Schematic of cell treatment, chromatin isolation, click chemistry, and 
selective isolation and elution of DNA. 
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RKO cells, which we have used extensively in all of our alkyne electrophile studies, were 
treated with DMSO or 25 µM aONE prior to chromatin extraction. Enrichment of histones in the 
chromatin faction was assessed by Coomassie staining (Figure 35A). DNA was sheared by 
sonication to an average fragment size of < 500 bp (Figure 35B), which is necessary for Illumina 
DNA sequencing. Following click chemistry conjugation of biotin to adducted proteins (Figure 
35C), biotinylated proteins were bound to streptavidin beads, washed, and eluted. The eluates were 
analyzed by agarose gel electrophoresis, which revealed the presence of DNA in the eluate from 
the aONE-treated, but not the control cells (Figure 35D).  
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Figure 35. Click-Seq method validation. RKO cells were treated with 25 µM aONE or DMSO for 3 h and chromatin 
was extracted. Chromatin (1mg) was subjected to click chemistry and adducts conjugated to N3-biotin, bound to beads, 
washed, and eluted according to the Click-Seq protocol described in Fig. A) Coomassie staining of input (0.5%) 
chromatin. B) Agarose gel electrophoresis of input DNA. C) Western blot analysis of input (0.5%), post-click (PC, 
1%) protein, and eluate (20%). D) Agarose gel electrophoresis of eluted DNA. 
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Western blot analysis of eluted proteins showed that H3 was selectively present in the 
samples from aONE-treated cells (Figure 35C, lanes 5 and 6). We further examined the eluate for 
the presence of all four core histones using western blot. We observed that histones H2A, H2B, 
H3 and H4 were all enriched in the eluate, with little to no detectable histones in the control elution 
(Figure 36). This result shows that protein complexes are dissociated under these conditions, which 
is known to occur. However, there was no streptavidin in the eluted samples (data not shown), 
suggesting that the adducted histone proteins remain associated with the beads, while other 
unadducted histones within the nucleosome octamer are eluted.   
 
 
Click-Seq shows distinct regions of enrichment in K562 cells from 25 µM aONE 
To assess the potential impact that ONE-mediated adducts have on chromatin structure and gene 
regulation, we employed Click-Seq to isolate and sequence the regions of DNA with which these 
adducts associate. K562 cells were used for these experiments as they had been extensively studied 
in the Encyclopedia of DNA elements (ENCODE) project. The cells were treated with aONE, and 
H2A
H3
H2B
H4
- +aONE
Figure 36. Click-Seq protein elution shows the four core histones. The Click-Seq protocol was performed on chromatin 
from cells treated with 25 µM aONE (+) or DMSO (-). Following the final elution, half of the eluted supernatant was 
precipitated with ice-cold methanol, centrifuged at 16,000 x g for 5 min, dried, and resuspended in 2X Laemmli sample 
buffer. Proteins were separated by SDS-PAGE, and western blot was performed using antibodies again all four core 
histones. All histones were present in the aONE eluate, but were at low or undetectable levels in the DMSO control. 
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chromatin was extracted. DNA was sheared to an average fragment size of < 500 bp via sonication. 
Following click chemistry-mediated conjugation of biotin to adducted proteins, biotinylated 
proteins were bound to streptavidin beads, washed, and eluted. ChIP sequencing libraries were 
generated for the DNA input and elution samples and sequenced with paired-end reads. 
Following ChIP library sequencing, paired-end sequences were aligned to the human 
genome, and regions of DNA enriched in the aONE-treated samples were examined. Thirteen 
enriched peaks were identified, mapping back to twelve genes and one region not associated with 
any RefSeq annotations (Table 5). One region of particular interest is within the TXNIP gene. 
TXNIP (thioredoxin interacting protein) interacts with thioredoxin at its active-site Cys residues. 
Overexpression of TXNIP results in decreased thioredoxin activity, decreased cell growth, and 
promotion of apoptosis.176-178 Enrichment was observed at the final exon of the TXNIP gene. Due 
to the role of thioredoxin in mediating the response to oxidative stress,179 this finding is especially 
intriguing, and more work is needed to determine if mRNA and protein levels of TXNIP are altered 
in response to ONE.  
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Chromosome Start End Length 
-log 
(p-value) 
Fold 
Enrichment 
Associated Gene 
chr1 145441341 145442294 954 7.26984 4.41908 TXNIP 
chr11 65266624 65268097 1474 21.33661 5.39616 MALAT1 
chr12 15095284 15095540 257 8.81985 5.54723 ARHGDIB 
chr12 92537470 92537968 499 6.72422 4.58353 BTG1 
chr15 45009852 45010263 412 25.78767 6.54398 B2M 
chr19 12902618 12904021 1404 8.37724 5.10707 JUNB 
chr2 43449929 43450540 612 7.84529 5.03318 ZNF36L2 
chr2 89156779 89157096 318 11.49731 5.9549 N/A 
chr2 92305742 92306009 268 7.60495 2.57251 TMSB10 
chr6 30461260 30461762 503 6.65824 3.79385 HLA-E 
chr6 31321681 31322048 368 10.1766 4.81204 HLA-B 
chr7 5566923 5568223 1301 13.06847 5.74017 ACTB 
chrX 12994983 12995255 273 12.39963 6.52527 TMSB4X 
 
ONE adducts on histones occur at levels comparable to those of canonical enzymatic modification  
Since the 4-ketoamide modification was observed in a physiologically relevant model of 
inflammation,88 we wanted to determine the levels of 4-Kam-Lys in chromatin. Recently, Galligan 
et al.175 developed Quantitative Analysis of Arginine and Lysine Modifications (QuARK-Mod), a 
method to quantify levels of modified amino acids in chromatin and individual histones. Using 
QuARK-Mod, we digested chromatin from RKO cells treated with 25 µM ONE or DMSO in the 
Table 5. Regions of enrichment from MACS2 in K562 cells 
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presence of an isotopically labeled 4-Kam-Lys internal standard. The resulting digest was analyzed 
by multiple reaction monitoring using the m/z 301.2à84.1 transition for the native 4-Kam-Lys 
and m/z 309.1à90.1 for the isotopically labeled standard. When normalized to Leu as a digestion 
control, levels of 4-Kam-Lys were ~0.72 pmol/nmol Leu in the treated samples, whereas the 
control did not have any detectable 4-Kam-Lys (Figure 37A). Levels of AcLys (Figure 37B) and 
me3Lys (Figure 37C) were almost two order of magnitude higher than the 4-Kam-Lys, while the 
less abundant ADMA (Figure 37) was only one order of magnitude higher. No significant 
differences in the canonical histone PTMs were observed upon ONE treatment. 
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Figure 37. Level of chromatin PTMs with ONE. RKO cells were treated with DMSO or 25 µM ONE for 3 h. Extracted 
chromatin was digested to single amino acids using the QuARK-Mod approach and the levels of different PTMs were 
determined using isotopically labeled internal standards. 
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To determine if 4-Kam-Lys was produced in a dose-dependent fashion, we exposed RKO 
cells to increasing levels of ONE then performed amino acid analysis of chromatin isolated from 
the cells. Interestingly, levels of 4-Kam-Lys following 100 µM ONE treatment (Figure 38) were 
higher than those of AcLys or me3Lys under basal conditions (Figure 37B and C). At 50 µM, the 
levels were comparable to those of ADMA (Figure 38). The 4-Kam-Lys was below the limit of 
detection at concentrations of ONE < 10 µM. These data show that the formation of this adduct on 
chromatin does not occur in a linear fashion, but rather increases rapidly between 50 µM and 100 
µM. 
 
 
ONE increases chromatin accessibility in a dose-dependent manner 
Previous reports have shown that the α,β-unsaturated carbonyl, acrolein, is capable of modifying 
histones in a manner similar to ONE.180 The authors showed that acrolein can adduct both free and 
nucleosomal histones, and exposure of cells results in increased chromatin accessibility as 
Figure 38. Dose-response relationship between ONE exposure and low abundance PTMs. RKO cells were treated 
with increasing concentrations of ONE for 3 h, and chromatin was extracted and subjected to QuARK-Mod. Levels 
of A) ADMA and B) 4-Kam-Lys were determined with isotopically labelled internal standards. 
A B
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measured by partial micrococcal nuclease (MNase) digestion.180 To assess chromatin accessibility 
in response to aONE, cells were treated with low (10 µM) or high (25 µM) aONE. Digestion with 
MNase and analysis of extracted DNA showed that treatment with aONE increased chromatin 
accessibility in a dose-dependent manner (Figure 39A-C).  Specifically, treatment with 25 µM 
aONE caused a significant increase in the amount of mononucleosomes after 5 min digestion 
(Figure 39D), suggesting that aONE adduction results in chromatin relaxation. 
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ONE adducts are long-lived histone modifications. 
The turnover rate for histone PTMs varies depending on the modification and the residue. On 
histone H3 in HeLa cells, there are 12 acetylation sites that exhibit rapid turnover (1-2 h) and 7 
sites that exhibit a turnover of > 30 h.181 PTMs with longer turnovers may contribute to differential 
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Figure 39. ONE increases chromatin accessibility. Chromatin from cells treated with A) DMSO, B) 10 µM ONE, or 
C) 25 µM ONE and digested with MNase for the indicated times. D) After 5min with MNase, DNA accessibility 
increases in a dose-dependent manner. 
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gene expression on a broader time scale. Furthermore, histone adduction by ONE may inhibit 
PTMs at key epigenetic sites, thereby exacerbating dysregulation of gene expression. 
Since the 4-Kam-Lys adduct is stable, we wanted to determine how long it remained on 
histones following an initial treatment. Using 25 µM aONE, we treated RKO cells in the absence 
of serum for 3 h. Then, we either collected the cells for chromatin extraction (0 h) or removed the 
medium and added fresh medium with or without serum for 24 h. Using click chemistry followed 
by SDS-PAGE and western blot with a streptavidin probe, we are able to observe the levels of 
adduction under these conditions. At the 0 h time point, there was a large amount of protein 
adduction following aONE treatment (Figure 40). After 24 h, the levels of adduction declined 
slightly in both the presence and absence of serum relative to the 0 h time point. Quantitation of 
these results revealed little difference in adduction between the treatments, though additional 
replicates may yield more definitive differences.  
 
 
Figure 40. Histone adducts are long-lived. RKO cells were treated with DMSO or 25 µM aONE for 3 h in serum-free 
medium. Cells were either collected (0 h) or the medium was replaced with fresh medium with or without serum for 
24 h. Chromatin was subjected to click chemistry, proteins separated by SDS-PAGE, and western blot with a 
streptavidin probe was used to measure amounts of adduction. Histone H3 was used as a loading control. Adduction 
decreased over time, but little differences were observed following 24 h between the with and without serum 
conditions. 
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Discussion 
Here, we have developed a technique that enables the selective isolation of DNA associated 
with aONE-modified chromatin proteins. Click chemistry can be used to conjugate biotin to 
adducted proteins within chromatin. This provides a significant advantage over traditional ChIP 
approaches. First, only proteins that have the alkyne will be biotinylated, which provides greater 
selectively over that of antibodies, which may bind non-specifically to many motifs/proteins. 
Second, this approach is applicable to many different adduct structures, such as the 4-ketoamide 
of Lys and the Michael adduct on His, since it only requires the presence of the alkyne. Antibodies 
would not provide such broad structural recognition without exhibiting a large loss of specificity.  
We applied this technique to the highly utilized K562 cell line to investigate chromatin 
alterations in response to aONE. The ENCODE consortium has performed hundreds of ChIP-Seq 
experiments, as well as a number of other DNA isolation and sequencing techniques, in this cell 
line, providing an ideal model for our studies. Very few regions of enrichment of adduct-associated 
DNA were found in the K562 cells using Click-Seq. All regions showing statistically significant 
enrichment, with the exception of one region on Chr2, were within an exonic region along a gene. 
Enrichment of some genes of interest, such as TXNIP, suggest that aONE may associate with some 
distinct regions. However, such few regions of enrichment suggest that aONE adducts occur 
broadly and nonspecifically on chromatin, thereby not contributing to enrichment in Click-Seq. 
Negative peaks were also not observed in these data, showing that there were no regions of de-
enriched DNA that would correlate to areas that were inaccessible to adduction.  
Recent work by Jin et al.174 shows that SIRT2 enzymatically removes the ONE adduct from 
4-Kam-Lys on histones, most notably on H3K27 and H3K23. The evidence that this ONE 
modification is enzymatically removable has large implications for its downstream effects on gene 
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expression. This also suggests that levels of the modification may be enzymatically regulated. 
Using the QuARK-Mod approach, we were able to determine that the 4-Kam-Lys is present at < 
1 pmol/nmol Leu in chromatin following 25 µM ONE treatment. These levels are almost two 
orders of magnitude lower than those of AcLys and me3Lys, the two most abundant histone 
modification, and within one order of magnitude from the lesser studied ADMA. 
Investigation into the dose dependence of these adducts showed that 4-Kam-Lys levels 
surpassed basal levels of AcLys and me3Lys at 50µM and 100µM ONE.   It is important to note 
that the levels of histone adducts we report only take into account the 4-Kam-Lys, but not the 
Michael adduct on His which was previously shown to be present on histones.88While we are 
currently unable to quantify the levels of the ONE-His adduct, these adducts will contribute to 
higher levels of ONE adducts on histone and may make the levels comparable to lower abundance 
modifications such as ADMA. 
The levels of 4-Kam-Lys did not increase in a linear manner, but rather increased rapidly 
at higher concentrations. This fits with observation by Codreanu et al.,84 which noted that the 
histones were members of the Class I protein group, which were only adducted at high 
concentrations of aONE. It is possible that at low concentrations, ONE may be preferentially 
conjugated to GSH and remain in the cytosol, whereas at higher concentrations, more ONE can 
bypass the cell detoxification systems in the cytosol and make it into the nucleus. Once in the 
nucleus, ONE can adduct histones and contribute to the potentially deleterious effect.  
 We investigated whether or not ONE can alter chromatin structure and increase 
accessibility following histone adduction. Using a partial MNase digestion, we showed that ONE 
increases chromatin accessibility, facilitating more rapid MNase digestion of chromatin to 
mononucleosomes. This outcome was similar to what has previously been observed with acrolein, 
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the simplest a,b-unsaturated carbonyl compound. Acrolein increases chromatin accessibility to 
MNase digestion, enabling increased transcription of genes within regions of greater 
accessibility.180 It is possible that ONE may have a similar effect on gene expression, which may 
not be observed using the Click-Seq method.  
 The longevity of these adducts may also contribute to dysregulation of chromatin structure 
and gene expression. The samples were not reduced with NaBH4, showing that the adducts present 
at 24 h were stable long-term. Since the doubling time of these cells is ~24 h, we would anticipate 
about a 50% reduction in histone modification in the serum-containing samples, though this was 
not observed. It is possible that newly synthesized histones may be targets of free aONE that has 
undergone a retro-Michael reaction or reversal of the Schiff base from other proteins in the cell, 
prior to reacting with the histone to form a more stable 4-ketoamide adduct. It is likely, though, 
that very low levels of free aONE would be produced by this reaction. 
While the Click-Seq method was developed for the study of aONE, it can also be applied 
to any biological studies that employ click chemistry. Much work has gone into the generating 
aminoacyltranferases which can accommodate non-natural amino acids, many of which have been 
used as click chemistry tools.182 The non-natural amino acids can then be incorporated into proteins 
at specific sites. Click-Seq can be used to study transcription factors that have been coded to 
include a non-natural alkyne-containing amino acid, providing more selective isolation without 
larger tags (e.g. FLAG, hexahistidine, etc.). Furthermore, it can be used to solely interrogate 
protein-protein binding, similar to co-immunoprecipitations. This method may provide a useful, 
reliable, and consistent approach to broad areas of biological investigation. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
 As discussed in Chapter I, inflammation is a beneficial process that combats infection, 
limits injury, and promotes healing. A large number of proinflammatory and chemically reactive 
species are produced during the inflammatory response. These species are primarily targeted 
against invading pathogens, but they can also have deleterious effects on host cells. Reactive 
oxygen (ROS) and reactive nitrogen species (RNS) can react with proteins, DNA, and lipids in 
host cells. 
 Of particular interest to our laboratory is the reaction of ROS/RNS with membrane lipids. 
Strong oxidants can abstract H-atoms from polyunsaturated fatty acids (PUFAs), forming lipid 
radicals that can react with molecular oxygen to generate lipid peroxyl radicals. The entire lipid 
peroxidation process can produce a collection of oxidized products, depending on the original 
PUFA. Additionally, these oxidized lipids can decompose to generate reactive a,b-unsaturated 
lipid aldehydes that can react with DNA and proteins, most notably at Cys, His, and Lys residues. 
The resultant electrophilic protein adducts are capable of altering protein function and activity. 
 4-Hydroxy-2-nonenal (HNE) is one of the most widely studied lipid electrophiles, and 4-
oxo-2-nonenal (ONE), the 4-keto cousin of HNE, is gaining increasing attention due to its higher 
reactivity. Both these electrophiles can covalently modify Cys, His, and Lys, but the structures of 
the resulting adducts differ greatly. HNE preferentially forms Michael adducts with all three 
residues, forming products that can undergo retro-Michael reaction at varying degrees unless 
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stabilized by reduction with NaBH4. ONE can also form Michael adducts at Cys, His, and Lys, 
although the predominant modification at Lys has been shown to be the 4-ketoamide adduct, a 
chemically stable modification that can be long-lived in the cell. Cross-linking is also more 
prevalent with ONE than with HNE; however identification and quantification of these cross-links 
remains technically challenging. 
 The application of click chemistry to the study of HNE and ONE has been instrumental in 
the discovery of their various targets. Alkyne analogues of HNE (aHNE) and ONE (aONE) were 
used in conjunction with click chemistry to generate protein inventories of the targets isolated from 
cells exposed to a range of electrophile concentrations. More than 1000 proteins were identified 
by this method, facilitating subsequent interrogation of individual protein targets for sites of 
modification, types of adducts, and functional implications of adduction. 
 An HNE target of particular interest was cyclin-dependent kinase 2 (CDK2), a main cell 
cycle regulator. Bioinformatic analysis of gene expression changes in response to HNE exposure 
and the inventory of HNE target proteins showed that the genes modulated by CDK2 were 
significantly down-regulated in response to HNE treatment and that CDK2 was itself a target of 
adduction.132 Alterations in CDK2 activity in cells as a result of adduction could be expected to 
affect cell growth, given the role of CDK2 in regulating the G1/S-phase transition. Thus, we sought 
to determine the sites of adduction on CDK2, the type(s) of adduct(s), and the consequences of 
modification on CDK2 activity and overall cell growth (Chapter II).  
 In studies using purified protein, we identified a number of sites of modification on CDK2, 
mainly on His residues, in the form of Michael adducts. Investigation of the crystal structure of 
CDK2 revealed two modified residues, His71 and His161, that may greatly impact CDK2 activity. 
His71 of CDK2 hydrogen bonds with Cyclin A, a potentially critical interaction as an association 
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between CKD2 and Cyclin A is required for CDK2 activity. His 161 immediately follows Thr160, 
a site of phosphorylation that activates CDK2. Adduction of both of these residues by CDK2 could 
inhibit CDK2 activity, resulting in the gene expression changes that were previously observed. 
 In vitro assessment revealed a loss of CDK2/CyclinA kinase activity in response to HNE 
treatment. This observation was recapitulated in RKO cells, confirming that CDK2 activity is 
significantly decreased in response to HNE. Furthermore, in cells synchronized in G1/G0, HNE 
treatment resulted in a delay in cell cycle progression from G1 to S-phase, thereby supporting the 
hypothesis that HNE-dependent inhibition of CDK2 kinase activity is physiologically relevant. 
 We then moved our focus to targets of ONE adduction. Peptidyl-prolyl cis/trans isomerase 
(PIN1) was identified as a target of both HNE and ONE, based on the proteomic adduct inventory. 
Previous work had focused on the effects of HNE on PIN1 by identifying the active site Cys as the 
main site of adduction.87 With ONE, the active site Cys was similarly modified, but the mass shift 
associated with the adduct was not the anticipated +158 m/z corresponding to a Michael adduct 
(Chapter III). Further investigation showed that the adduct was insensitive to reduction with 
NaBH4, suggesting that it did not retain the aldehyde or ketone groups.  
Selective covalent blockade allowed us to decipher which residue(s) were associated with 
Pin1-ONE adduct. Blocking Cys resulted in the disappearance of the adducted peptides, as did 
blocking Lys. This information led to the hypothesis that this modification was an ONE crosslink 
between Cys and Lys. We were able to identify a novel cross-link between the active site Cys 
(Cys113) and Lys117 by mass spectrometry. Modification of Cys113 would abolish catalytic 
activity and inactivate PIN1. Using deuterated analogues of ONE, we were able to propose a 
mechanism for cross-link formation. While this is only the second publication on an ONE cross-
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link between two residues on a protein, our computational work suggested that a number of 
additional proteins may be susceptible to formation of a similar cross-link.  
As shown in previous work,88 histones are preferential targets for ONE adduction, and their 
high Lys content makes them highly susceptible to 4-ketoamide formation. Gene expression is 
extensively regulated by post-translation modifications (PTMs) of histones, mainly on Lys 
residues. Chromatin immunoprecipitation and sequencing (ChIP-Seq) is traditionally used to 
assess the regions of the genome with which a particular histone PTM associates. This technique 
requires antibodies that are highly specific for the PTM as well as the histone of interest. This 
method presents obvious issues for the investigation of ONE adducts on histones, necessitating 
multiple antibodies for distinct adduct type (e.g., Michael adduct, 4-ketoamide, etc.). We aimed to 
develop an approach that allows us to bypass the use of antibodies by employing click chemistry.  
Combining ChIP-Seq and click chemistry allowed us to develop the chromatin click 
precipitation and sequencing (Click-Seq) technique. This method enabled selective isolation of 
DNA associated with adducted chromatin proteins by conjugating N3-biotin to aONE-modified 
chromatin proteins and capturing them with streptavidin. Isolated DNA was then sequenced by 
Illumina sequencing and analyzed according to established ChIP-Seq pipelines. 
While Click-Seq allowed us to determine DNA sequences that were selectively associated 
with ONE-dependent modifications, we also wanted to assess the magnitude of the ONE adduct 
burden in cells. Our laboratory has recently developed Quantitative Analysis of Arginine and 
Lysine Modifications (QuARK-Mod) to measure the levels of PTMs on Lys and Arg. Using this 
approach, we were able to determine that 4-Kam-Lys levels were approximately two orders of 
magnitude lower than those of the canonical AcLys and me3Lys PTMs following treatment with 
25 µM ONE. Using a dose-response curve with increasing concentrations of ONE, we did not 
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observe a linear increase in the formation of 4-Kam-Lys. Surprisingly, at higher concentrations of 
ONE, levels of 4-Kam-Lys surpassed levels of AcLys and me3Lys. The levels of Lys modifications 
declined at the higher ONE concentrations, though the levels of ADMA were unaltered, showing 
that the alterations in histone modifications was Lys specific. These observations open up a new 
area of investigation into the regulation and cross-talk of histone modifications. 
 
Future Directions 
Cross-linking of proteins by ONE 
 Our collaboration with Dr. Jarrod Smith has suggested a number of proteins that may be 
cross-linked by ONE. We attempted to detect a cross-link within thioredoxin (TRX), but those 
efforts did not reveal any Cys modifications. On the other hand, there were multiple Lys residues 
that were adducted. All of these adducts were the 4-ketoamide modification. Since TRX is known 
to be adducted by HNE at the active site Cys residues (Cys32/Cys35),172,2 it is conceivable that 
ONE may also be able to modify these residues. We believe that the complete absence of any Cys 
adducts may be due to extensive disulfide bond formation in the protein. While it is also possible 
that very low concentrations of ONE may contribute to extensive cross-linking, the high 
percentage of sequence coverage in the treated samples suggests that this is likely not occurring. 
 Moving forward, we can investigate additional proteins that were identified by our 
computational approach. We have exhaustively characterized another protein on the list, PKM2, 
using LC-MS/MS to identify sites of adduction.183 This glycolytic enzyme is modified by both 
HNE and ONE at Cys and His residues in the form of Michael adducts. No cross-links were 
observed by mass spectrometry, despite the overwhelming evidence by SDS-PAGE and 
Coomassie staining that recombinant PKM2 monomers were cross-linked following in vitro 
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modification with ONE. Inter-protein cross-linking of individual PKM2 monomers would be 
difficult to detect by LC-MS/MS. We were only able to identify the PIN1 cross-link because it 
joined Cys and Lys residues on the same peptide, resulting in a relatively small mass shift. To 
further investigate possible PKM2 cross-links, a MALDI-MS approach, which would be a 
complementary approach to LC-MS/MS, could be utilized to search for interpeptide cross links.  
 There still remain 28 proteins on the potential cross-link list that can be investigated. For 
all of these, available crystal structures and knowledge of a protein’s enzymatic activity can be 
useful in selecting the most ideal proteins for these studies. The computation approach that we 
used searched for proteins that have Cys/His/Lys within 10 Å, though proteins containing a 
catalytic Cys, similar to Pin1, may simplify identification of cross-links. Using the previously 
published reactive Cys inventory,2 we can determine which of the remaining 28 proteins have 
reactive Cys residues. From there, we can interrogate the crystal structures to determine which of 
these contain nearby Lys residues. We can employ this activity- and structure-based selection to 
allow for the best protein for mass spectrometric identification of intraprotein cross-links. 
 
Measuring gene expression changes from ONE 
Gene expression alterations have been studied extensively by both microarray and RNA-
Seq following HNE treatment in RKO cells.132,94 A number of genes associated with antioxidant 
(HMOX1, GCLM, TXNRD1) and stress responses (ZFAND2A, GADD45B, DNAJB4, BAG3) are 
induced in response to 30 µM HNE treatment for 6 h. There were also genes that were identified 
which had no connection to canonical cell stress responses, such as upregulation of the ADM gene, 
which encodes a preprohormone that plays a role in the vasculature and has antimicrobial activity. 
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It is possible that alterations in histone modifications as a result of adduction by HNE contributed 
to some dysregulation of gene expression.  
It is possible that similar alterations in gene expression will be present with ONE. While 
we lack gene expression data for ONE, we expect that antioxidant and stress responses will be 
activated due to the presence of the electrophile. Dysregulation of gene expression may occur due 
to ONE adduction of histones, thereby altering expression of genes which would not typically be 
expressed in response to electrophiles. To accomplish this, RNA-Seq can be used to measure 
changes in gene expression under basal conditions and in response to ONE treatment. This will 
provide data that can be correlated with the Click-Seq data, allowing for a more comprehensive 
picture of the impact of ONE-dependent adduction of histones. 
 
Click-Seq for long-term alterations in chromatin structure 
Our data presented in Chapter IV show that ONE-derived histone adducts are stable for at 
least 24 h under normal cell growth conditions. The apparent longevity of aONE-histone adducts 
may contribute to a long-lived effect on differential gene expression. Adduction of Lys residues 
that are known sites of epigenetic regulation, such as H3K27, would block this residue from other 
PTMs, thereby altering the histone code and deregulating gene expression. The disruption of 
canonical epigenetic regulation may contribute to dysregulation of gene expression immediately 
following ONE exposure, but may also persist throughout the lifetime of the adducted histone. 
We propose to utilize the Click-Seq method to interrogate the regions where these adducts 
are present 24 h post-treatment. Cells can be treated with aONE for three hours and then removed 
for 24 h in medium with and without serum. Click-Seq can then be used to assess regions of 
enrichment and we can then compare the results to the Click-Seq results obtained immediately 
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following ONE treatment. The results may also provide additional insight into how canonical 
histone modifications are altered by ONE adduction. Chromatin immunoprecipitation and 
sequencing (ChIP-Seq) can be performed with antibodies targeting known histone marks, such as 
H3K27Ac, which are also known to be adducted. This approach would allow us to determine if 
ONE can alter enrichment patterns of canonical histone modifications, thereby disrupting 
chromatin regulation. 
 
Click-seq method to identify binding partners of adducted chromatin proteins 
 The Click-Seq method has provided a means to interrogate the DNA that is associated with 
adducted chromatin proteins, however, it also has the potential for investigation into proteins that 
associate with the adducted proteins. As shown in the Click-Seq method development in Chapter 
IV, the western blot loading control for the input and post-click samples, histone H3, was present 
in the streptavidin affinity eluate of aONE- but not DMSO-treated cells. Using western blot with 
antibodies for the four core histones, we were further able to determine that all of the four core 
histones are present in the aONE eluate and the levels are much lower or nonexistent in the DMSO 
control.  
With these data, we hypothesize that the Click-Seq method will facilitate the isolation of 
proteins that associate with aONE-modified chromatin. In a preliminary proteomic identification 
of the eluted proteins, all the core histones were observed as well as many other chromatin-
associated proteins. SIRT2, which has been shown to enzymatically remove the 4-ketoamide 
adduct from Lys,174 was not identified by this method. Additional proteomic experiments can be 
designed to better investigate the proteins eluted in this assay and determine specific versus 
nonspecific hits. A dose-response including a range of aONE concentrations, similar to the 
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experimental design in Codreanu et al.,84 would provide more confident identification of potential 
binding partners which associate with 4-Kam-Lys  and other aONE adducts. 
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